0001104659-20-057715.txt : 20200507 0001104659-20-057715.hdr.sgml : 20200507 20200507070135 ACCESSION NUMBER: 0001104659-20-057715 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 67 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 731408526 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 20854505 BUSINESS ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 10-Q 1 tm2014488d1_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2020

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No.: 001-36534

IRADIMED CORPORATION

(Exact name of Registrant as specified in its charter)

Delaware		73-1408526
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification Number

1025 Willa Springs Drive
Winter Springs, Florida		32708
(Address of principal executive offices)		(Zip Code)

(407) 677-8022

(Registrant’s telephone number, including area code)

N/A

(Former Name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:		Trading Symbol		Name of each exchange on which registered:
Common stock, par value $0.0001		IRMD		NASDAQ Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

Large accelerated filer o		Accelerated filer x

Non-accelerated filer ¨		Smaller reporting company x
		Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes o No o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The registrant had 12,049,978 shares of common stock, par value $0.0001 per share, outstanding as of May 1, 2020.

IRADIMED CORPORATION

Table of Contents

				Page
Part I	Financial Information

	Item 1	Condensed Financial Statements		2

		(a)	Condensed Balance Sheets as of March 31, 2020 (Unaudited) and December 31, 2019	2

		(b)	Condensed Statements of Operations for the Three Months Ended March 31, 2020 and 2019 (Unaudited)	3

		(c)	Condensed Statements of Comprehensive Income for the Three Months Ended March 31, 2020 and 2019 (Unaudited)	4

		(d)	Condensed Statements of Stockholders’ Equity for the Three Months Ended March 31, 2020 and 2019 (Unaudited)	5

		(e)	Condensed Statements of Cash Flows for the Three Months Ended March 31, 2020 and 2019 (Unaudited)	6

		(f)	Notes to Unaudited Condensed Financial Statements	7

	Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations		14

	Item 3	Quantitative and Qualitative Disclosures About Market Risk		20

	Item 4	Controls and Procedures		20

Part II	Other Information

	Item 1	Legal Proceedings		21

	Item 1A	Risk Factors		21

	Item 2	Unregistered Sale of Equity Securities and Use of Proceeds		38

	Item 3	Default Upon Senior Securities		38

	Item 4	Mine Safety Disclosures		38

	Item 5	Other Information		38

	Item 6	Exhibits		39

Signatures				40

PART I. FINANCIAL INFORMATION

Item 1. Condensed Financial Statements

IRADIMED CORPORATION
CONDENSED BALANCE SHEETS

	March 31, 2020		December 31, 2019
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	44,636,348	$	43,481,781
Accounts receivable, net of allowance for doubtful accounts of $104,547 as of March 31, 2020 and $69,093 as of December 31, 2019		5,851,843		7,293,303
Investments		2,782,162		2,768,287
Inventory, net		4,214,961		3,641,561
Prepaid expenses and other current assets		753,334		407,802
Prepaid income taxes		2,271,948		1,370,947
Total current assets		60,510,596		58,963,681
Property and equipment, net		2,099,778		2,053,806
Intangible assets, net		901,378		860,087
Operating lease right-of-use asset		2,897,007		2,955,873
Deferred income taxes, net		1,692,445		1,663,415
Other assets		266,757		232,002
Total assets	$	68,367,961	$	66,728,864
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	$	873,332	$	993,742
Accrued payroll and benefits		1,623,375		2,166,209
Other accrued taxes		126,826		596,576
Warranty reserve		89,685		81,761
Deferred revenue		1,814,209		1,671,420
Current portion of operating lease liability		244,474		240,843
Other current liability		108,421		108,421
Total current liabilities		4,880,322		5,858,972
Deferred revenue		2,773,802		2,630,467
Operating lease liability, less current portion		2,652,533		2,715,030
Total liabilities		10,306,657		11,204,469
Stockholders’ equity:
Common stock; $0.0001 par value; 31,500,000 shares authorized; 11,970,937 shares issued and outstanding as of March 31, 2020 and 11,765,875 shares issued and outstanding as of December 31, 2019		1,197		1,177
Additional paid-in capital		19,949,639		19,192,394
Retained earnings		38,069,661		36,300,450
Accumulated other comprehensive income		40,807		30,374
Total stockholders’ equity		58,061,304		55,524,395
Total liabilities and stockholders’ equity	$	68,367,961	$	66,728,864

See accompanying notes to unaudited condensed financial statements.

IRADIMED CORPORATION

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	For the Three Months Ended March 31,
	2020			2019
Revenue	$	8,677,541		$	8,437,593
Cost of revenue		2,213,730			2,047,827
Gross profit		6,463,811			6,389,766
Operating expenses:
General and administrative		2,862,727			2,412,696
Sales and marketing		2,433,567			2,110,652
Research and development		430,282			352,573
Total operating expenses		5,726,576			4,875,921
Income from operations		737,235			1,513,845
Other income, net		98,502			92,574
Income before provision for income taxes		835,737			1,606,419
Provision for income tax benefit		(933,474	)		(239,146	)
Net income	$	1,769,211		$	1,845,565
Net income per share:
Basic	$	0.15		$	0.17
Diluted	$	0.14		$	0.15
Weighted average shares outstanding:
Basic		11,891,428			11,029,639
Diluted		12,365,605			12,227,696

See accompanying notes to unaudited condensed financial statements.

IRADIMED CORPORATION

CONDENSED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

	For the Three Months Ended March 31,
	2020		2019
Net income	$	1,769,211	$	1,845,565
Other comprehensive income:
Change in fair value of available-for-sale securities, net of tax expense of $3,442 and $11,656, respectively		10,433		35,317
Realized loss on available-for-sale securities reclassified to net income, net of tax benefit of $0 and $949, respectively		—		2,877
Other comprehensive income		10,433		38,194
Comprehensive income	$	1,779,644	$	1,883,759

See accompanying notes to unaudited condensed financial statements.

IRADIMED CORPORATION

CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

	For the Three Months Ended March 31,
	2020			2019
Common stock:
Balance at beginning of period	$	1,177		$	1,099
Net share settlement of restricted stock units		1			—
Exercise of stock options and warrants		19			15
Balance at end of period		1,197			1,114

Additional paid-in capital:
Balance at beginning of period		19,192,394			15,317,335
Stock compensation expense		568,958			382,353
Net share settlement of restricted stock units		(133,873	)		(22,507	)
Exercise of stock options and warrants		322,160			456,724
Balance at end of period		19,949,639			16,133,905

Retained earnings:
Balance at beginning of period		36,300,450			26,669,491
Net income		1,769,211			1,845,565
Balance at end of period		38,069,661			28,515,056

Accumulated other comprehensive income:
Balance at beginning of period		30,374			(42,192	)
Other comprehensive income		10,433			38,194
Balance at end of period		40,807			(3,998	)

Total stockholders’ equity	$	58,061,304		$	44,646,077

See accompanying notes to unaudited condensed financial statements.

IRADIMED CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended March 31,
	2020			2019
Operating activities:
Net income	$	1,769,211		$	1,845,565
Adjustments to reconcile net income to net cash provided by operating activities:
Change in allowance for doubtful accounts		36,756			21,450
Change in provision for excess and obsolete inventory		128,143			120,529
Depreciation and amortization		344,784			387,081
Stock-based compensation		568,958			382,353
Deferred income taxes, net		(32,472	)		59,048
Loss on maturities of investments		—			3,826
Changes in operating assets and liabilities:
Accounts receivable		1,404,704			(1,140,008	)
Inventory		(560,996	)		(333,546	)
Prepaid expenses and other current assets		(538,093	)		(665,862	)
Other assets		(60,614	)		(4,891	)
Accounts payable		(266,644	)		375,202
Accrued payroll and benefits		(542,834	)		(378,354	)
Other accrued taxes		(469,750	)		(46,832	)
Warranty reserve		7,924			(341	)
Deferred revenue		308,559			338,078
Prepaid income taxes		(901,001	)		(298,094	)
Net cash provided by operating activities		1,196,635			665,204
Investing activities:
Proceeds from maturity of investments		—			650,000
Purchases of property and equipment		(166,593	)		(82,943	)
Capitalized intangible assets		(63,782	)		(9,724	)
Net cash (used in) provided by investing activities		(230,375	)		557,333
Financing activities:
Proceeds from exercises of stock options		322,179			456,739
Taxes paid related to the net share settlement of equity awards		(133,872	)		(22,507	)
Net cash provided by financing activities		188,307			434,232
Net increase in cash and cash equivalents		1,154,567			1,656,769
Cash and cash equivalents, beginning of period		43,481,781			28,027,688
Cash and cash equivalents, end of period	$	44,636,348		$	29,684,457
Supplemental disclosure of cash flow information:
Right-of-use asset recognized in exchange for new lease obligation	$	—		$	3,182,724
Operating and short-term lease payments recorded within cash flow from operating activities	$	107,081		$	106,659

See accompanying notes to unaudited condensed financial statements.

IRADIMED CORPORATION

Notes to Unaudited Condensed Financial Statements

1 — Basis of Presentation

The accompanying interim condensed financial statements of IRADIMED CORPORATION (“IRADIMED”, the “Company”, “we”, “our”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally presented in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. The interim financial information is unaudited, but reflects all normal adjustments that are, in the opinion of management, necessary for the fair presentation of our financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.

These accompanying interim condensed financial statements should be read with the financial statements and related footnotes to financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019. The accounting policies followed in the preparation of these interim condensed financial statements, except as described in Note 1, are consistent in all material respects with those described in Note 1 of our Form 10-K.

We operate in one reportable segment which is the development, manufacture and sale of MRI compatible medical devices, related accessories, disposables and services for use by hospitals and acute care facilities during MRI procedures.

Certain Significant Risks and Uncertainties

COVID-19 Considerations

We are subject to risks and uncertainties as a result of the spread of COVID-19. The extent of the impact of COVID-19 on our business is highly uncertain and difficult to predict. Our future results of operations and liquidity could be adversely impacted by delays in payments, supply chain disruptions, and uncertain demand. As of the date of the issuance of these financial statements, the extent to which COVID-19 may materially impact our financial condition, liquidity, or results of operations in future periods is uncertain.

Recent Accounting Pronouncements

Recently Issued Accounting Pronouncements to be Implemented

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 will be effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We do not expect ASU 2019-12 to have a material impact on financial condition, results of operations or cash flows.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. In November 2018, April 2019 and May 2019, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses and ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, which provided additional implementation guidance on ASU 2016-03. The previously mentioned ASUs are effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We do not expect the adoption of these ASUs to have a material impact on our financial condition, results of operations or cash flows.

2 — Revenue Recognition

Disaggregation of Revenue

We disaggregate revenue from contracts with customers by geographic region and revenue type as we believe it best depicts the nature, amount, timing and uncertainty of our revenue and cash flow.

Revenue information by geographic region is as follows:

	Three Months Ended March 31,
	2020		2019
	(unaudited)
United States	$	6,322,106	$	7,073,735
International		2,355,435		1,363,858
Total revenue	$	8,677,541	$	8,437,593

Revenue information by type is as follows:

	Three Months Ended March 31,
	2020		2019
	(unaudited)
Devices:
MRI compatible IV infusion pump system	$	2,664,834	$	4,192,754
MRI compatible patient vital signs monitoring systems		2,888,703		1,766,608
Total Devices revenue		5,553,537		5,959,362
Disposables, services and other		2,662,713		2,036,674
Amortization of extended warranty agreements		461,291		441,557
Total revenue	$	8,677,541	$	8,437,593

Contract Liabilities

Our contract liabilities consist of:

	March 31, 2020		December 31, 2019
		(unaudited)
Advance payments from customers	$	35,306	$	12,765
Shipments in-transit		22,345		4,250
Extended warranty agreements		4,530,360		4,284,872
Total	$	4,588,011	$	4,301,887

Changes in the contract liabilities during the periods presented are as follows:

	Deferred Revenue
Contract liabilities, December 31, 2019	$	4,301,887
Increases due to cash received from customers		779,048
Decreases due to recognition of revenue		(492,924	)
Contract liabilities, March 31, 2020	$	4,588,011

	Deferred Revenue
Contract liabilities, December 31, 2018	$	3,605,789
Increases due to cash received from customers		813,298
Decreases due to recognition of revenue		(652,564	)
Contract liabilities, March 31, 2019	$	3,766,523

Capitalized Contract Costs

Our capitalized contract costs consist of:

	March 31, 2020		December 31, 2019
	(unaudited)
Capitalized contract costs	$	412,863	$	352,250

Expense related to the amortization of capitalized contract costs was $28,169 and $22,713 for the three months ended March 31, 2020 and 2019, respectively.

3 — Basic and Diluted Net Income per Share

Basic net income per share is based upon the weighted-average number of common shares outstanding during the period. Diluted net income per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. Stock options and restricted stock units granted by us represent the only dilutive effect reflected in diluted weighted-average shares outstanding.

The following table presents the computation of basic and diluted net income per share:

	Three Months Ended March 31,
	2020		2019
	(unaudited)
Net income	$	1,769,211	$	1,845,565
Weighted-average shares outstanding — Basic		11,891,428		11,029,639
Effect of dilutive securities:
Underwriters’ warrants		—		99,814
Stock options		414,439		996,303
Restricted stock units		59,738		101,940
Weighted-average shares outstanding — Diluted		12,365,605		12,227,696
Basic net income per share	$	0.15	$	0.17
Diluted net income per share	$	0.14	$	0.15

Stock options and restricted stock units excluded from the calculation of diluted net income per share because the effect would have been anti-dilutive are as follows:

	Three Months Ended March 31,
	2020		2019
	(unaudited)
Anti-dilutive stock options and restricted stock units		62,904		7,123

4 — Inventory

Inventory consists of:

	March 31, 2020			December 31, 2019
	(unaudited)
Raw materials	$	3,513,972		$	2,939,451
Work in process		282,198			229,479
Finished goods		647,509			697,483
Inventory before allowance for excess and obsolete		4,443,679			3,866,413
Allowance for excess and obsolete		(228,718	)		(224,852	)
Total	$	4,214,961		$	3,641,561

5 — Property and Equipment

Property and equipment consist of:

	March 31, 2020			December 31, 2019
	(unaudited)
Computer software and hardware	$	647,988		$	627,624
Furniture and fixtures		1,117,693			1,112,550
Leasehold improvements		225,841			225,841
Machinery and equipment		1,796,394			1,778,524
Tooling in-process		291,642			163,105
		4,079,558			3,907,644
Accumulated depreciation		(1,979,780	)		(1,853,838	)
Total	$	2,099,778		$	2,053,806

Depreciation expense of property and equipment was $126,308 and $124,341 for the three months ended March 31, 2020 and 2019, respectively.

Property and equipment, net, information by geographic region is as follows:

	March 31, 2020		December 31, 2019
	(unaudited)
United States	$	1,757,458	$	1,689,740
International		342,320		364,066
Total property and equipment, net	$	2,099,778	$	2,053,806

Long-lived assets held outside of the United States consist principally of tooling and machinery and equipment, which are components of property and equipment, net.

6 — Intangible Assets

The following table summarizes the components of intangible asset balances:

	March 31, 2020			December 31, 2019
	(unaudited)
Patents — in use	$	304,270		$	304,270
Patents — in process		139,641			120,581
Internally developed software — in use		867,569			867,569
Internally developed software — in process		124,808			80,721
Trademarks		26,768			26,133
		1,463,056			1,399,274
Accumulated amortization		(561,678	)		(539,187	)
Total	$	901,378		$	860,087

Amortization expense of intangible assets was $22,491 for the three months ended March 31, 2020 and 2019.

Expected annual amortization expense for the remaining portion of 2020 and the next five years related to intangible assets is as follows (excludes in process intangible assets):

Nine months ending December 31, 2020	$	67,472
2021		89,963
2022		89,392
2023		88,740
2024		88,439
2025		87,446

7 — Investments

Our investments consist of corporate bonds that we have classified as available-for-sale and are summarized in the following tables:

	March 31, 2020
	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Corporate bonds:
U.S. corporations	$	2,258,686	$	45,342	$	—	$	2,304,028
International corporations		471,139		6,995		—		478,134
Total	$	2,729,825	$	52,337	$	—	$	2,782,162

	December 31, 2019
	Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Corporate bonds:
U.S. corporations	$	2,258,686	$	29,123	$	—	$	2,287,809
International corporations		471,139		9,339		—		480,478
Total	$	2,729,825	$	38,462	$	—	$	2,768,287

8 — Fair Value Measurements

The fair values of cash equivalents, accounts receivables, net and accounts payable approximate their carrying amounts due to their short duration.

The fair value of our assets and liabilities subject to recurring fair value measurements are as follows:

	Fair Value at March 31, 2020
	Fair Value		Quoted Prices in Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Corporate bonds:
U.S. corporations	$	2,304,028	$	—	$	2,304,028	$	—
International corporations		478,134		—		478,134		—
Total	$	2,782,162	$	—	$	2,782,162	$	—

	Fair Value at December 31, 2019
	Fair Value		Quoted Prices in Active Market for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Corporate bonds:
U.S. corporations	$	2,287,809	$	—	$	2,287,809	$	—
International corporations		480,478		—		480,478		—
Total	$	2,768,287	$	—	$	2,768,287	$	—

Our corporate bonds are valued by a third-party custodian at closing prices from secondary exchanges or pricing vendors on the valuation date.

There were no transfers into or out of any Levels during the three months ended March 31, 2020 or the year ended December 31, 2019.

9 — Accumulated Other Comprehensive Income

The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2020 and 2019 are as follows:

	Unrealized (Losses) Gains on Available-For-Sale Securities
Balance at December 31, 2019	$	30,374
Gains on available-for-sale securities, net		10,433
Reclassification realized in net earnings		—
Balance at March 31, 2020	$	40,807

Balance at December 31, 2018	$	(42,192	)
Gains on available-for-sale securities, net		35,317
Reclassification realized in net earnings		2,877
Balance at March 31, 2019	$	(3,998	)

10 — Stock-Based Compensation

Stock-based compensation was recognized as follows in the Condensed Statements of Operations:

	Three Months Ended March 31,
	2020		2019
	(unaudited)
Cost of revenue	$	58,254	$	62,524
General and administrative		362,152		219,705
Sales and marketing		130,955		82,131
Research and development		17,597		17,993
Total	$	568,958	$	382,353

As of March 31, 2020, we had $500,552 of unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of 3.4 years. As of March 31, 2020, we had $4,805,263 of unrecognized compensation cost related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of 3.1 years.

The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2020 (shares):

	Stock Options			Restricted Stock Units
Outstanding beginning of period		638,860			297,048
Awards granted		—			18,129
Awards exercised/vested		(190,540	)		(19,844	)
Awards canceled		(500	)		(25,724	)
Outstanding end of period		447,820			269,609

11 — Income Taxes

For the three months ended March 31, 2020, we recorded a provision for income tax benefit of $(933,474). Our effective tax rate was (111.7) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation and a U.S. state tax benefit. Additionally, we recognized a benefit in our effective tax rate resulting from the Coronavirus Aid, Relief, and Economic Security Act, which allowed us to carryback the net operating loss to years prior to the enactment of the Tax Cuts and Jobs Act.

For the three months ended March 31, 2019, we recorded a provision for income tax benefit of $(239,146). Our effective tax rate was (14.9) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation, partially offset by U.S. state tax expense.

As of March 31, 2020 and December 31, 2019, we had not identified or accrued for any uncertain tax positions. We are currently unaware of any uncertain tax positions that could result in significant payments, accruals or other material deviations in this estimate over the next 12 months. We believe that our tax positions comply in all material respects with applicable tax law. However, tax law is subject to interpretation, and interpretations by taxing authorities could be different from ours, which could result in the imposition of additional taxes and penalties.

We file tax returns in the United States Federal jurisdiction and many U.S. state jurisdictions. The Company is subject to income tax examinations for our United States Federal and certain U.S. state income taxes for 2016 and subsequent years and various other U.S. state income taxes for 2015 and subsequent years.

12 — Leases

We have only one material lease contract outstanding. In January 2014, we entered into a non-cancelable operating lease, commencing July 1, 2014, for our manufacturing and headquarters facility in Winter Springs, Florida owned by Susi, LLC, an entity controlled by our Chairman of the Board and Chief Technology Officer, Roger Susi. Pursuant to the terms of our lease for this property, the monthly base rent is $34,133, adjusted annually for changes in the consumer price index. Under the terms of the lease, we are responsible for property taxes, insurance and maintenance expenses. Prior to May 31, 2019, the expiration date of the initial lease term, and pursuant to the terms of the lease contract, we renewed the lease for an additional five years, resulting in a new lease expiration date of May 31, 2024. Unless advance written notice of termination is timely provided, the lease will automatically renew for one additional successive term of five years beginning in 2024, and thereafter, will be renewed for successive terms of one year each. For purposes of Topic 842, we concluded that we will exercise both of the five-year options, resulting in a remaining lease term of 9.2 years as of March 31, 2020. This lease agreement does not contain any residual value guarantee or material restrictive covenants.

Operating lease cost recognized in the Condensed Statements of Operations is as follows:

	Three Months Ended March 31,
	2020		2019
Cost of revenue	$	46,535	$	46,535
General and administrative		46,044		46,044
Sales and marketing		2,604		2,605
Research and development		7,215		7,215
Total	$	102,398	$	102,399

Lease costs for short-term leases were immaterial for the three months ended March 31, 2020.

Maturity of Operating Lease Liability as of March 31, 2020 is as follows:

Nine months ending December 31, 2020	$	307,197
2021		409,596
2022		409,596
2023		409,596
2024		409,596
Thereafter		1,809,050
Total lease payments		3,754,631
Imputed interest		(857,624	)
Present value of lease liability	$	2,897,007

13 — Commitments and Contingencies

Purchase commitments. We had various purchase orders for goods or services totaling $3,631,996 and $3,208,174 as of March 31, 2020 and December 31, 2019, respectively. No amounts related to these purchase orders have been recognized in our balance sheet.

Legal matters. We may from time to time become party to various legal proceedings or claims that arise in the ordinary course of business.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition (“MD&A”) supplements the MD&A in the Company’s Annual Report filed on Form 10-K. The MD&A should be read in conjunction with the “Risk Factors” section contained in Part II, Item 1A of this Quarterly Report, our condensed financial statements and accompanying footnotes, the Form 10-K and the cautionary information regarding forward-looking statements at the beginning of this section.

Some of the statements contained in this MD&A and elsewhere in this Quarterly Report are forward-looking statements that involve substantial risks and uncertainties. All statements other than historical facts contained in this report, including statements regarding our future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “may,” “will,” “continue,” “should,” “plan,” “predict,” “potential” and other similar expressions. We have based these forward-looking statements on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Our actual results could differ materially from those anticipated in these forward-looking statements, which are subject to a number of risks, uncertainties and assumptions including, but not limited to the risks discussed in the Risk Factor section of this Quarterly Report.

Our Business

We develop, manufacture, market and distribute Magnetic Resonance Imaging (“MRI”) compatible medical devices and accessories and services relating to them.

We are a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically-ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated to remain immobile during an MRI scan.

Each IV infusion pump system consists of an MRidium® MRI compatible IV infusion pump, non-magnetic mobile stand, proprietary disposable IV tubing sets and many of these systems contain additional optional upgrade accessories.

Our 3880 MRI compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI scanner room. The IRADIMED 3880 has a compact, lightweight design allowing it to travel with the patient from their critical care unit, to the MRI and back, resulting in increased patient safety through uninterrupted vital signs monitoring and decreasing the amount of time critically ill patients are away from critical care units. The features of the IRADIMED 3880 include: wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo® algorithms; non-magnetic respiratory CO2; invasive and non-invasive blood pressure; patient temperature, and; optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The IRADIMED 3880 MRI compatible patient vital signs monitoring system has an easy-to-use design and allows for the effective communication of patient vital signs information to clinicians.

We generate revenue from the sale of MRI compatible medical devices and accessories, extended warranty agreements, services related to maintaining our products and the sale of disposable products used with our devices. The principal customers for our MRI compatible products include hospitals and acute care facilities, both in the United States and internationally.

Historical selling cycles for our devices have varied widely and are typically three to six months in duration. We also enter into agreements with healthcare supply contracting companies in the U.S., which enable us to sell and distribute our products to their member hospitals. Under these agreements, we are required to pay these group purchasing organizations (“GPOs”) a fee of three percent of the sales of our products to their member hospitals. Our current GPO contracts effectively give us the ability to sell to more than 95 percent of all U.S. hospitals and acute care facilities.

Financial Highlights

Our revenue increased $0.3 million, or 2.8 percent, to $8.7 million for the first quarter ended March 31, 2020, compared to $8.4 million for the first quarter last year. Net income was $1.8 million, or $0.14 per diluted share in the first quarter ended March 31, 2020, compared to $1.8 million, or $0.15 per diluted share in the first quarter last year.

COVID-19 Impact

In March 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic, which continues to spread throughout the U.S. and the world and has resulted in authorities implementing numerous measures to contain the virus, including travel bans and restrictions, quarantines, shelter-in-place orders, business limitations and shutdowns. While we are unable to accurately predict the full impact that COVID-19 will have on our results from operations, financial condition, liquidity and cash flows due to numerous uncertainties, including the duration and severity of the pandemic and containment measures, our compliance with these measures has impacted our day-to-day operations and could disrupt our business and operations, as well as that of our customers and suppliers, for an indefinite period of time. Considering the significant uncertainties created by COVID-19, we have withdrawn our 2020 financial guidance.

We have taken several steps to support the health and well-being of our employees as a result of the pandemic, including:

Restricted the travel of our field sales and clinical support teams.

Implemented remote working arrangements where possible for a portion of our staff.

Adopted more stringent cleaning procedures at our headquarters and manufacturing facility.

Adopted policies guaranteeing a portion of compensation for employees that are subject to variable compensation plans and allowing all employees to donate their accrued time off to other employees unable to work due to COVID-19 issues.

The COVID-19 pandemic has resulted, and is likely to continue to result, in significant economic disruption across the globe and has and will likely continue to adversely affect our business. Much of the sales cycle for products recognized in revenue during the first quarter 2020 was completed in the fourth quarter 2019. Additionally, as we progressed through the first quarter 2020, and the impact of COVID-19 continued to spread throughout the world, we experienced an acceleration in the decline of customer orders for our products as our customers began to defer decisions to purchase our products into future periods. Also during this time, many of our hospital customers began restricting access to healthcare workers only, diminishing our ability to generate sales, which may delay the timing of future orders and may result in declining revenue for the remaining portion of 2020.

Our business may also be adversely impacted as a result of the pandemic’s global economic impact. For example, hospitals may curtail their overall capital spending, or we may be unable to collect receivables from customers significantly impacted by COVID-19. Also, a decrease in orders in a given period could negatively affect our revenues in future periods from sales of our disposables and extended maintenance contracts, particularly if experienced on a sustained basis.

We believe that our current cash, cash equivalents and any cash generated from operations will be sufficient to meet our ongoing operating requirements for at least the next 12 months. We do not anticipate requiring additional capital; however, if required or desirable, we may seek to obtain a credit facility, raise debt or issue additional equity in private or public markets.

We will continue to monitor the situation and may take further actions altering our business operations that we determine are in the best interest of our employees, customers, partners, suppliers, and stockholders, or as required by federal, state, or local authorities.

Application of Critical Accounting Policies

We prepare our financial statements in conformity with GAAP. The preparation of these financial statements requires us to make estimates and use assumptions that affect the reported amounts of assets, liabilities and related disclosures at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

We believe that the following critical accounting policies require the use of significant estimates, assumptions, and judgments:

Revenue recognition;

Accounts receivable and allowance for doubtful accounts;

Inventory carried at the lower of cost or net realizable value;

Stock-based compensation; and

Income taxes.

These critical accounting policies are described in more detail in our Annual Report filed on Form 10-K, under Management’s Discussion and Analysis and Results of Operations. Except as disclosed in Note 1 to the unaudited condensed financial statements contained herein related to the adoption of recent accounting pronouncements, there have been no changes to these policies during the three months ended March 31, 2020.

The use of different estimates, assumptions, and judgments could have a material effect on the reported amounts of assets, liabilities and related disclosures as of the date of the financial statements and revenue and expenses during the reporting period.

Results of Operations

The following table sets forth selected statements of operations data as a percentage of total revenue for the periods indicated. Our historical operating results are not necessarily indicative of the results for any future period.

	Percent of Revenue Three Months Ended March 31,
	2020			2019
Revenue		100.0	%		100.0	%
Cost of revenue		25.5			24.3
Gross profit		74.5			75.7
Operating expenses:
General and administrative		33.0			28.6
Sales and marketing		28.0			25.0
Research and development		5.0			4.2
Total operating expenses		66.0			57.8
Income from operations		8.5			17.9
Other income, net		1.1			1.1
Income before provision for income taxes		9.6			19.0
Provision for income tax benefit		(10.8	)		(2.8	)
Net income		20.4	%		21.9	%

Three Months Ended March 31, 2020 and 2019

Revenue by Geographic Region

	Three Months Ended March 31,
	2020		2019		Change
United States	$	6,322,106	$	7,073,735		(10.6	)%
International		2,355,435		1,363,858		72.7	%
Total revenue	$	8,677,541	$	8,437,593		2.8	%

Revenue by Type

	Three Months Ended March 31,
	2020		2019		Change
Devices:
MRI compatible IV infusion pump system	$	2,664,834	$	4,192,754		(36.4	)%
MRI compatible patient vital signs monitoring systems		2,888,703		1,766,608		63.5	%
Total Devices revenue		5,553,537		5,959,362		(6.8	)%
Disposables, services and other		2,662,713		2,036,674		30.7	%
Amortization of extended maintenance contracts		461,291		441,557		4.5	%
Total revenue	$	8,677,541	$	8,437,593		2.8	%

For the three months ended March 31, 2020, revenue increased $0.3 million, or 2.8 percent, to $8.7 million from $8.4 million for the same period in 2019.

Revenue from sales in the U.S. decreased $(0.8) million, or (10.6) percent, to $6.3 million from $7.1 million for the same period in 2019. Revenue from sales internationally increased $1.0 million, or 72.7 percent, to $2.4 million from $1.4 million for the same period in 2019. Domestic sales accounted for 72.9 percent of revenue in the first quarter 2020, compared to 83.8 percent in the first quarter 2019.

Revenue from sales of devices decreased $(0.4) million, or (6.8) percent, to $5.6 million from $6.0 million for the same period in 2019.

The average selling price of our MRI compatible IV infusion pump system during the three months ended March 31, 2020 was approximately $29,900, compared to approximately $35,800 for the same period in 2019. The decrease in ASP relates to higher international sales of our MRI compatible IV infusion pump recognized in revenue when compared to the same period in 2019.

The average selling price of our MRI compatible patient vital signs monitoring system during the three months ended March 31, 2020 was approximately $35,400, compared to approximately $37,400 for the same period in 2019. The decrease in ASP relates to higher international sales of our 3880 MRI compatible patient vital signs monitoring system recognized in revenue when compared to the same period in 2019.

Revenue from sales of our disposables, services and other increased $0.7 million, or 30.7 percent, to $2.7 million from $2.0 million for the same period in 2019. Revenue from the amortization of extended maintenance contracts increased $0.1 million, or 4.5%, to $0.5 million from $0.4 million for the same period in 2019.

Cost of Revenue and Gross Profit

	Three Months Ended March 31,
	2020			2019
Revenue	$	8,677,541		$	8,437,593
Cost of revenue		2,213,730			2,047,827
Gross profit	$	6,463,811		$	6,389,766
Gross profit percentage		74.5	%		75.7	%

For the three months ended March 31, 2020, cost of revenue increased $0.2 million, or 8.1 percent, to $2.2 million from $2.0 million for the same period in 2019. Gross profit increased $0.1 million, or 1.2 percent, to $6.5 million for the first quarter 2020 from $6.4 million for the same period in 2019. The increase in cost of revenue and gross profit is primarily due to higher revenue. Gross profit margin was 74.5 percent for first quarter 2020, compared to 75.7 percent for the first quarter 2019. The decrease in gross profit margin is due to higher international revenue as a percent of total revenue, partially offset by unfavorable inventory costing adjustments recognized during the first quarter 2019.

Operating Expenses

	Three Months Ended March 31,
	2020			2019
General and administrative	$	2,862,727		$	2,412,696
Percentage of revenue		33.0	%		28.6	%
Sales and marketing	$	2,433,567		$	2,110,652
Percentage of revenue		28.0	%		25.0	%
Research and development	$	430,282		$	352,573
Percentage of revenue		5.0	%		4.2	%

General and Administrative

For the three months ended March 31, 2020, general and administrative expense increased $0.5 million, or 18.7 percent, to $2.9 million from $2.4 million for the same period last year. This increase is primarily due to higher expenses related to payroll and employee benefits costs resulting from increased headcount, stock compensation and legal and professional expenses.

Sales and Marketing

For the three months ended March 31, 2020, sales and marketing expense increased $0.3 million, or 15.3 percent, to $2.4 million from $2.1 million for the same period last year. This increase is primarily the result of higher payroll and employee benefits costs resulting from increased headcount, partially offset by lower sales commissions expense.

Research and Development

For the three months ended March 31, 2020 and 2019, research and development expense was consistent at $0.4 million resulting from higher expenses related to payroll and employee benefits costs due to increased headcount and recruiting costs, offset by lower expenses related to consulting and outside engineering services.

Other Income, Net

Other income, net consists of interest income, foreign currency gains and losses, and other miscellaneous income. For the three months ended March 31, 2020 and 2019, we reported other income of approximately $99,000 and $93,000, respectively. This increase is primarily due to higher interest income.

Income Taxes

Liquidity and Capital Resources

Our principal sources of liquidity have historically been our cash and cash equivalents balances, our investments, cash flow from operations and access to the financial markets. Our principal uses of cash are operating expenses, working capital requirements, capital expenditures and share repurchases.

As of March 31, 2020, we had cash, cash equivalents and investments of $47.4 million, stockholders’ equity of $58.1 million, and working capital of $55.6 million. As of December 31, 2019, we had cash and cash equivalents and investments of $46.3 million, stockholders’ equity of $55.5 million, and working capital of $53.1 million.

	Three Months Ended March 31,
	2020			2019
Net cash provided by operating activities	$	1,196,635		$	665,204
Net cash (used in) provided by investing activities		(230,375	)		557,333
Net cash provided by financing activities		188,307			434,232

Cash provided by operating activities increased $0.5 million to $1.2 million for the three months ended March 31, 2020, compared to $0.7 million for the same period in 2019. During the quarter ended March 31, 2020, cash provided by operations was positively impacted by cash inflows from accounts receivable and deferred revenue, and negatively impacted by prepaid income taxes, inventory, accrued payroll and benefits, and prepaid expenses and other current asssets.

Cash used in investing activities was $(0.2) million for the three months ended March 31, 2020 primarily due to purchases of property and equipment and the capitalization of intangible assets. For the three months ended March 31, 2019, cash provided by investing activities as $0.6 million primarily due to proceeds from the maturities of investments, partially offset by purchases of property and equipment.

Cash provided by financing activities decreased $(0.2) million to $0.2 million for the three months ended March 31, 2020, compared to $0.4 million for the same period in 2019. This decrease primarily relates to lower cash inflows from the exercise of stock options and higher cash outflows for taxes paid for the net share settlement of restricted stock units.

Our manufacturing and headquarters facility has been leased from Susi, LLC, an entity controlled by our Chairman of the Board and Chief Technology Officer, Roger Susi. Pursuant to the terms of our lease, the monthly base rent is $34,133, adjusted annually for changes in the consumer price index.

Off-Balance Sheet Arrangements

Under our amended and restated bylaws, we have agreed to indemnify our officers and directors for certain events or occurrences arising as a result of the officer or director serving in such capacity. We have a director and officer liability insurance policy that limits our exposure under these indemnifications and enables us to recover a portion of any future loss arising out of them. In addition, in the normal course of business, we enter into contracts that contain indemnification clauses whereby the Company indemnifies our customers against damages associated with product failures. We have obtained liability insurance providing coverage that limits our exposure for these indemnified matters. Based on our historical experience and the estimated probability of future loss, we have determined that the estimated fair value of these indemnities is not material to our financial position or results of operations and have not recorded a liability for these agreements as of March 31, 2020. We had no other off-balance sheet arrangements during the three months ended March 31, 2020 or for the year ended December 31, 2019 that had, or are reasonably likely to have, a material effect on our financial condition, results of operations, or liquidity.

Contractual Obligations

There have been no material changes outside the ordinary course of business to our contractual obligations and commercial commitments since December 31, 2019.

Recent Accounting Pronouncements

See Note 1 to the unaudited condensed financial statements contained herein for a full description of recent accounting pronouncements including the respective expected dates of adoption and status of evaluation of expected effects on results of our operations and financial condition.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Exchange Risk

We have foreign currency risks related to our revenue and operating expenses denominated in currencies other than the U.S. Dollar, principally the Japanese yen (“Yen”). The volatility of the Yen depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income because of transaction gains (losses) related to revaluing Yen denominated accounts payable balances. In the event our Yen denominated accounts payable or expenses increase, our operating results may be affected by fluctuations in the Yen exchange rate. If the U.S. Dollar uniformly increased or decreased in strength by 10% relative to the Yen, our net income would have correspondingly increased or decreased by an immaterial amount for the three months ended March 31, 2020 and 2019.

Interest Rate Risk

When able, we invest excess cash in bank money-market funds, corporate debt securities or discrete short-term investments. The fair value of our cash equivalents and short-term investments is sensitive to changes in the general level of interest rates in the U.S., and the fair value of these investments will decline if market interest rates increase. As of March 31, 2020, we had $2.8 million in corporate bonds, with $0.5 million maturing in less than 1 year and $2.3 million maturing between 1 and 3 years. These corporate bonds have fixed interest rates and semi-annual interest payment dates. If market interest rates were to change by 100 basis points from levels at March 31, 2020, we expect the corresponding change in fair value of our investments would be approximately $32,000. This is based on sensitivity analyses performed on our financial position as of March 31, 2020. Actual results may differ as our analysis of the effects of changes in interest rates does not account for, among other things, sales of securities prior to maturity and repurchase of replacement securities, the change in mix or quality of the investments in the portfolio, and changes in the relationship between short-term and long-term interest rates.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

We may from time to time become party to various legal proceedings or claims that arise in the ordinary course of business. Our management reviews these matters if and when they arise and believes that the resolution of any such matters currently known will not have a material effect on our results of operations or financial position.

Item 1A. Risk Factors

Risks Relating to Our Business and Financial Condition

Our business, financial condition and operations may be materially adversely affected by the COVID-19 pandemic or other public health crises.

The COVID-19 pandemic, and the resulting restrictions intended to slow the spread of COVID-19, including stay-at-home orders, business shut downs and other restrictions, has and will likely continue to adversely affect our business in a number of ways. To respond to the demands of managing COVID-19 and the resulting economic uncertainties, healthcare organizations may be forced to adjust spending priorities by increasing spending related to COVID-19, which may have a significant effect on the demand and available budget for our products. The financial strains on healthcare systems may also lead to an increased risk of delays in customer payments. In addition, a recession resulting from the spread of COVID-19 could materially affect our business, especially if a recession results in higher unemployment causing potential patients to not have access to health insurance. Our ability to generate sales may be further disrupted by hospitals restricting access to hospital workers only. A decline in operating results could limit our generation of capital resources and cause financial stress if we are unable to increase revenues or adjust our costs appropriately to changes in revenue. We believe that COVID-19’s adverse impact on our operating results, cash flows and financial condition will be primarily driven by the severity and duration of the pandemic and its impact on the U.S. and global economy.

In addition to adversely impacting demand for our products, COVID-19 or other public health crises could have an adverse impact on our manufacturing capacity, supply chains, and distribution systems as we and other businesses and governments take preventative and precautionary measures designed to slow the spread of COVID-19. We could experience other negative impacts of COVID-19 relating to lack of availability of our key personnel or temporary closures of our office or the facilities of our suppliers or third-party service providers.

The future progression of the COVID-19 pandemic and its resulting impacts on our customers, sales activity, supply chain and distribution networks are highly uncertain at this time. However, the foregoing and other disruptions as a result of COVID-19 could have a material adverse effect on our business, operating results and financial condition, especially to the extent these impacts persist or exacerbate over an extended period of time.

Our financial performance is significantly dependent on a limited number of products, and disruptions in our ability to sell these products may have a material adverse effect on our business.

Our current revenue and profitability are significantly dependent on the sale of the MRidium 3860+ MRI compatible IV infusion pump system, the 3880 MRI compatible patient vital signs monitoring system (both Class II medical devices) and the ongoing sale of related disposables and services.

In the past, the FDA issued us a warning letter that impacted our ability to commercially distribute our MRidium 3860+ MRI compatible IV infusion pump system. Although we have resolved this warning letter and resumed commercial distribution of the MRidium 3860+ MRI compatible IV infusion pump system, there can be no guarantee that the FDA will not take similar action in the future. The FDA could require us to cease shipment of our products, notify health professionals and others that the devices present unreasonable risk or substantial harm to public health, order a recall, repair, replacement, or refund of the devices, detain or seize adulterated or misbranded medical devices, or ban the medical devices. The FDA may also issue further warning letters or untitled letters, refuse future requests for 510(k) submission or premarket approval, revoke existing 510(k) clearances or premarket approvals previously granted, impose operating restrictions, enjoin and restrain certain violations of applicable law pertaining to medical devices and assess civil or criminal penalties against our officers, employees, or us.

Our products could be rendered obsolete or economically impractical by numerous factors, many of which are beyond our control, including but not limited to:

entrance of new competitors into our markets;

technological advancements of MRI scanners;

technological developments such as new imaging modalities which render MRI procedures obsolete or reduce the instances where MRI imaging is utilized;

loss of key relationships with suppliers, group purchasing organizations, or end-user customers;

manufacturing or supply interruptions;

product liability claims;

our reputation and product market acceptance;

loss of existing regulatory approvals or the imposition of new requirements to maintain such approvals; and

product recalls or safety alerts.

Any major factor adversely affecting the sale of our products or services would cause our revenues to decline and have a material adverse impact on our business, financial condition and our common stock.

We have significant international sales as well as international supply chain links and we face risks related to health epidemics that could adversely affect our revenue.

Our business could be adversely impacted by the effects of COVID-19 or other epidemics, particularly since we have experienced an increasing concentration of sales in the Asia-Pacific region. The recent COVID-19 outbreak has negatively impacted our revenues recently and may continue to do so in the future. With respect to our international distributors, some customers that are implementing heightened security policies may inhibit the inability of our international distributors to access hospitals for purposes of selling our products and may cause delays of orders for our products and negatively affect our revenues.

Our materials suppliers could also be disrupted by conditions related to COVID-19, or other epidemics, possibly resulting in disruption to our supply chain. If our suppliers are unable or fail to fulfill their obligations to us for any reason, we may not be able to manufacture our products and satisfy customer demand or our obligations under sales agreements in a timely manner, and our business could be harmed as a result.

At this point in time, there is uncertainty relating to the potential effect of COVID-19 on our business. Infections may become more widespread or may recur at a later time and, should that limit our ability to timely sell and distribute our products or cause supply disruptions, it would have a negative impact on our business, financial condition and operating results. In addition, a significant health epidemic could adversely affect the economies and financial markets of many countries, resulting in an economic downturn that could affect demand for our products which could have a material adverse effect on our business, operating results and financial condition.

We have been subject to securities class action litigation and derivative litigation and we may be subject to similar or other litigation in the future.

In the past, following adverse action by the FDA or volatility in our stock price, securities class action litigation has been brought against us. There can be no assurance that we will not face other securities litigation in the future. With respect to any litigation, our insurance may not reimburse us or may not be sufficient to reimburse us for the expenses or losses we may suffer in contesting and concluding such lawsuits. A decision adverse to our interests on these actions or resulting from these matters could result in the payment of substantial damages and could have a material adverse effect on our business, financial condition and our common stock. Regardless of the outcome, these claims may result in injury to our reputation, significant costs, diversion of management’s attention and resources, and loss of revenue.

There is no assurance that our internal and external sources of liquidity will at all times be sufficient for our cash requirements.

We must have sufficient sources of liquidity to fund our working capital requirements, our capital improvement plans, and execute on our strategic initiatives. A decline in operating results could limit our generation of capital resources and cause financial stresses if we are unable to increase revenues or adjust our costs appropriately to changes in revenue. Further, future new product launches may demand increased working capital before any long-term return is realized from increased revenue. Our ability to achieve our business and cash flow plans is based on a number of assumptions which involve significant judgments and estimates of future performance, borrowing capacity and credit availability, which cannot at all times be assured. Accordingly, there is no assurance that cash flows from operations and other internal and external sources of liquidity will at all times be sufficient for our cash requirements. If necessary, we may need to consider actions and steps to improve our cash position and mitigate any potential liquidity shortfall, such as modifying our business plan, pursuing additional financing to the extent available, reducing capital expenditures, pursuing and evaluating other alternatives and opportunities to obtain additional sources of liquidity and other potential actions to reduce costs. There can be no assurance that any of these actions would be successful, sufficient or available on favorable terms. Any inability to generate or obtain sufficient levels of liquidity to meet our cash requirements at the level and times needed could have a material adverse impact on our business and financial position.

Our continued success depends on the integrity of our supply chain, including multiple single-source suppliers, the disruption of which could negatively impact our business.

Many of the component parts of our products are obtained through supply agreements with third parties. Some of these parts require our partners to engage in complex manufacturing processes and involve long lead times or delivery periods. Considering our dependence on third-party suppliers, several of which are single-source suppliers, we are subject to inherent uncertainties and risks related to their ability to produce or deliver parts on a timely basis, to comply with product safety and other regulatory requirements and to provide quality parts to us at a reasonable price.

For example, we are dependent upon a single vendor for the ultrasonic motor at the core of our devices. If this vendor fails to meet our volume requirements, which we anticipate will increase over time, or if the vendor becomes unable or unwilling to continue supplying motors to us, this would impact our ability to supply our devices to customers until a replacement source is secured. Our executed agreement with this vendor provides that the price at which we purchase products from the vendor is determined by agreement from time to time or should material costs change. Although we have had a long history of stable pricing with this supplier, this provision may make it difficult for us to continue to receive motors from this vendor on favorable terms or at all if we do not agree on pricing in the future. In such event, it could materially and adversely affect our commercial activities, operating results and financial condition.

In the near term, we do not anticipate finding alternative sources for our primary suppliers, including single source suppliers. Therefore, if our primary suppliers become unable or unwilling to manufacture or deliver materials, or manufacture or deliver such materials later than anticipated, we could experience protracted delays or interruptions in the supply of materials which would ultimately delay our manufacture of products for commercial sale, which could materially and adversely affect our development programs, commercial activities, operating results and financial condition.

Additionally, any failure by us to forecast demand for, or to maintain an adequate supply of raw materials, parts, or finished products, could result in an interruption in the supply of certain products and a decline in our sales.

We rely on third-party suppliers for certain of our raw materials and components.

We rely on unaffiliated third-party suppliers for certain raw materials and components necessary for the manufacturing and operation of our products. Certain of those raw materials and components are proprietary products of those unaffiliated third-party suppliers and are specifically cited in our applications with regulatory agencies so that they must be obtained from that specific sole source or sources and could not be obtained from another supplier unless and until an appropriate application amendment is approved by the regulatory agency.

Among the reasons we may be unable to obtain these raw materials and components include, but are not limited to:

a supplier’s inability or unwillingness to continue supplying raw materials and/or components;

regulatory requirements or action by regulatory agencies or others, including changes in international trade treaties and/or tariffs;

adverse financial or other strategic developments at or affecting the supplier, including bankruptcy;

unexpected demand for or shortage of raw materials or components;

failure of the supplier to comply with quality standards which results in quality and product failures, product contamination and/or recall;

discovery of previously unknown or undetected imperfections in raw materials or components;

labor disputes or shortages, including from natural disasters and the effects of health emergencies such as COVID-19; and

political instability and actual or anticipated military or political conflicts.

These events could negatively impact our ability to satisfy demand for our products, which could have a material adverse effect on our products’ use and sales and our business and results of operations. We may experience these or other shortages in the future resulting in delayed shipments, supply constraints, contract disputes and/or stock-outs of our products.

The manufacture of our products requires strict adherence to regulatory requirements governing medical devices and if we or our suppliers encounter problems our business could suffer.

The manufacture of our products must comply with strict regulatory requirements governing Class II medical devices in the U.S. and other regulatory requirements in foreign locations. Problems may arise during manufacturing, quality control, storage or distribution of our products for a variety of reasons, including equipment malfunction, failure to follow specific protocols and procedures, manufacturing quality concerns, or problems with raw materials, electromechanical, software and other components, supplier issues, and natural disasters. If problems arise during production, the affected products may have to be discarded. Manufacturing problems or delays could also lead to increased costs, lost sales, damage to customer relations, failure to supply penalties, time and expense spent investigating the cause and, depending on the cause, similar losses with respect to other batches of products. If problems are not discovered before the product is released to the market, voluntary recalls, corrective actions or product liability related costs may also be incurred. Should we encounter difficulties in the manufacture of our products or be subject to a product recall, our business could suffer materially.

Our markets are very competitive and we sell certain of our products in a mature market.

The market for our 3880 MRI compatible patient vital signs monitoring system is well-developed and sales growth for our monitor could be slow. Our vital signs monitoring system could face difficult competition, including competitors offering lower prices, which could have an adverse effect on our revenue and margins. Our competitors may have certain advantages, which include the ability to devote greater resources to the development, promotion, and sale of their products. Consequently, we may need to increase our efforts, and related expenses for research and development, marketing, and selling to maintain or improve our position. We may not realize the per unit revenue we have planned for and expect. Continued sales to our existing customers are expected to be significant to our revenue in the future, and if our existing customers do not continue to purchase from us, our revenue may decline.

We manufacture and store our products at a single facility in Florida.

We manufacture and store our products at a single facility in Winter Springs, Florida. If by reason of fire, hurricane or other natural disaster, or for any other reason, the facility is destroyed or seriously damaged or our access to it is limited, our ability to provide products to our customers would be seriously interrupted or impaired and our operating results and financial condition would be materially and negatively affected.

Our inability to collect on our accounts receivables held by customers may have an adverse effect on our business operations and financial condition.

We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. From time to time, we have had, and may in the future have, accounts receivables from one or more customers that accounted for 10 percent or more of our gross accounts receivable. As a result, we may be exposed to a certain level of concentration of credit risk. If a major customer experiences financial difficulties, the effect on us could be material and have an adverse effect on our business, financial condition and results of operations.

If we fail to maintain relationships with Group Purchasing Organizations, sales of our products could decline.

Our ability to sell our products to U.S. hospitals, acute care facilities and outpatient imaging centers depends in part on our relationships with Group Purchasing Organizations (“GPOs”). Many existing and potential customers for our products are members of GPOs. GPOs negotiate pricing arrangements and contracts, which are sometimes exclusive, with medical supply manufacturers and distributors, and these negotiated prices are made available to a GPO’s affiliated hospitals and other members. We pay the GPOs an administrative fee in the form of a percentage of the volume of products sold to their affiliated hospitals and other members. If we are not an approved provider selected by a GPO, affiliated hospitals and other members may be less likely to purchase our products. Should a GPO negotiate a sole source or bundling contract covering a future or current competitor’s products, we may be precluded from making sales of our competing products to members of that GPO for the duration of the contractual arrangement. For example, even if we have an existing contract with a GPO for sales of our MRidium 3860+ MRI compatible IV infusion pump, we may encounter difficulties in selling, or be unable to sell, our 3880 MRI compatible patient vital signs monitoring system to that GPO’s affiliated hospitals and other members, which may result in a longer sales cycle or an inability to sell. Our failure to renew contracts with GPOs may cause us to lose market share and could have a material adverse effect on our sales, financial condition and results of operations. In the future, if another competitive supplier emerges, and we fail to keep our relationships and develop new relationships with GPOs, our competitive position would likely suffer.

Cost-containment efforts of our customers and purchasing groups could adversely affect our sales and profitability.

Our MRI compatible medical devices are considered capital equipment by many potential customers, and hence changes in the budgets of healthcare organizations and the timing of spending under these budgets and conflicting spending priorities, such as spending related to COVID-19, may have a significant effect on the demand for our products and related services. Any decrease in expenditures by these healthcare facilities could decrease demand for our products and related services and reduce our revenue. Additionally, changes to reimbursement policies by third-party payors could also decrease demand for our products and related services and reduce our revenue.

Any failure in our efforts to access and educate clinicians, anesthesiologists, radiologists, and hospital administrators regarding the advantages of our products could significantly limit our product sales.

We believe our future success will require us to educate a sufficient number of clinicians, anesthesiologists, radiologists, hospital administrators and other purchasing decision-makers about our products and the costs and benefits of our products. If we fail to demonstrate the safety, reliability and economic benefits of our products to hospitals and acute medical facilities, our products may not be adopted and our expected and actual sales would suffer.

The lengthy sales cycle for medical devices could delay our sales.

The decision-making process of customers is often complex and time-consuming. Based on our experience, we believe the period between initial discussions with customers regarding our products and a customer’s purchase of our products is typically three to six months. Sales cycles can also be delayed because of capital budgeting procedures. Moreover, even if one or two units are sold to a hospital, we believe that it will take additional time and experience with our products before other medical professionals routinely use them for other procedures and in other departments of the hospital. Such time would delay potential sales of additional units and disposable products or additional optional accessories to that medical facility or hospital. These delays could have an adverse effect on our business, financial condition and results of operations.

Because we rely on distributors to sell our products outside of the U.S., our revenues could decline if our existing distributors do not continue to purchase products from us or if our relationship with any of these distributors is terminated.

We rely on distributors for all our sales outside the U.S. and hence do not have direct control over foreign sales activities. These distributors also assist us with regulatory approvals and the education of physicians and government agencies. Our revenues outside the U.S. have recently represented approximately one-fifth of our net revenues. If our existing international distributors fail to sell our products or sell at lower levels than we anticipate, we could experience a decline in revenues or fail to meet our forecasts. We cannot be certain that we will be able to attract new international distributors nor retain existing ones that market our products effectively or provide timely and cost-effective customer support and service. None of our existing distributors are obligated to continue selling our products.

If we do not successfully develop and commercialize enhanced products or new products that remain competitive, we could lose revenue opportunities and customers, and our ability to achieve growth would be impaired.

The medical device industry is characterized by rapid product development and technological advances, which places our products at risk of obsolescence. Our long-term success depends upon the development and successful commercialization of new products, new or improved technologies and additional applications for MRI compatible infusion, therapeutic, diagnostic and safety products and services. The research and development process is time-consuming and costly and may not result in products or applications that we can successfully commercialize. If we do not successfully adapt our technology, products and applications, we could lose revenue opportunities and customers. In addition, we may not be able to improve our products or develop new products or technologies quickly enough to maintain a competitive position in our markets and continue to grow our business.

We are highly dependent on our founder, Chairman and Chief Technology Officer, Roger Susi.

We believe that Mr. Susi will play a significant role in the development of new products. Our current and future operations could be adversely impacted if we were to lose his services. Accordingly, our success will be dependent on appropriately managing the risks related to maintaining his continued services.

If we fail to attract and retain the talent required for our business, our business could be materially harmed.

Competition for highly skilled personnel is often intense in the medical device industry, including in the MRI compatible medical device segment. If our current employees with experience in the MRI compatible device industry leave our company, we may have difficulty finding replacements with an equivalent amount of experience and skill, which could harm our operations. Our future success will also depend in part on our ability to identify, hire and retain additional personnel, including executives, skilled engineers to develop new products and sales and production staff. We may not be successful in attracting, integrating or retaining qualified personnel to meet our current growth plans or future needs. Our productivity may be adversely affected if we do not integrate and train our new employees quickly and effectively.

Any one of our executive officers or other key employees could terminate his or her relationship with us at any time. The loss of one or more of our executive officers or key employees, and any failure to have in place and execute an effective succession plan for key executive officers, could significantly delay or prevent us from achieving our business and/or development objectives and could materially harm our business. Changes in our executive management team may also cause disruptions in, and harm to, our business. As previously disclosed, Roger Susi, our founder and our former chief executive officer, transitioned to his new role as chief technology officer and Leslie McDonnell was appointed to replace him as chief executive officer effective August 19, 2019. Although we strive to reduce the challenges of this transition and the appointment of our new chief executive officer, failure to ensure effective transfer of knowledge and a smooth transition could disrupt or adversely affect our business, results of operations, financial condition and prospects.

We may also have difficulty finding and retaining qualified Board members. Any failure to do so could be perceived negatively and could adversely affect our business.

Also, to the extent we hire personnel from competitors, we may be subject to allegations that we have improperly solicited, or that they have divulged proprietary or other confidential information, or that their former employers own their inventions or work product.

We may be unable to scale our operations successfully.

We are working to expand our size and scale via more penetration of existing markets and the launch of new complementary products. This growth, if it occurs as planned, will place significant demands on our management and manufacturing capacity, as well as our financial, administrative and other resources. We cannot guarantee that any of the personnel, systems, procedures and controls we put in place will be adequate to support the manufacture and distribution of our products. Our operating results will depend substantially on the ability of our officers and key employees to manage changing business conditions and to implement and improve our financial and administrative systems and manage other resources. If we are unable to respond to and manage changing business conditions, or the scale of our products, services and operations, then the quality of our services, our ability to retain key personnel and our business could be harmed.

We engage in related party transactions, which result in a conflict of interest involving our management.

We have engaged in the past, and continue to engage, in related party transactions, particularly between our company and Roger Susi and his affiliates. The only significant ongoing related party transaction is the lease agreement between our company and Susi, LLC, an affiliate of Roger Susi, with respect to our sole production and headquarters facility in Winter Springs, Florida. Related party transactions present difficult conflicts of interest, could result in disadvantages to our company and may impair investor confidence, which could materially and adversely affect us. Related party transactions could also cause us to become materially dependent on related parties in the ongoing conduct of our business, and related parties may be motivated by personal interests to pursue courses of action that are not necessarily in the best interests of our company and our stockholders.

Any acquisitions of technologies, products and businesses, may be difficult to integrate, could adversely affect our relationships with key customers, and/or could result in significant charges to earnings.

We plan to periodically review potential acquisitions of technologies, products and businesses that are complementary to our products and that could accelerate our growth. However, our company has never completed an acquisition and there can be no assurance that we will be successful in finding any acquisitions in the future. The process of identifying, executing and realizing attractive returns on acquisitions involves a high degree of uncertainty. Acquisitions typically entail many risks and could result in difficulties in integrating operations, personnel, technologies and products. If we are not able to successfully integrate our acquisitions, we may not obtain the advantages and synergies that the acquisitions were intended to create, which may have a material adverse effect on our business, results of operations, financial condition and cash flows, our ability to develop and introduce new products and the market price of our stock.

The environment in which we operate makes it increasingly difficult to accurately forecast our business performance.

Significant changes and volatility in most aspects of the current business environment, including financial markets, consumer behavior, speed of technological, regulatory and competitive changes, make it increasingly difficult for us to predict our revenues and earnings into the future. Our quarterly sales and profits depend substantially on the volume and timing of orders fulfilled during the quarter, and such orders are difficult to forecast. Product demand is dependent upon the capital spending budgets of our customers and prospects as well as government funding policies and matters of public policy as well as product and economic cycles that can affect the spending decisions of these entities. As a result, any revenue, earnings or financial guidance or outlook which we have given or might give may turn out to be inaccurate. Though we will endeavor to give reasonable estimates of future revenues, earnings and financial information at the time we give such guidance, based on then-current conditions, there is a significant risk that such guidance or outlook will turn out to be incorrect. Historically, companies that have overstated their operating guidance have suffered significant declines in their stock price when such results are announced to the public.

There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with GAAP. Furthermore, portions of GAAP require the use of fair value models which are variable in application and methodology from appraiser to appraiser. Any changes in estimates, judgments and assumptions used could have a material adverse effect on our business, financial position and operating results.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such assumptions and estimates include those related to revenue recognition, accruals for product returns, allowances for doubtful accounts, valuation of inventory, impairment of intangibles and long-lived assets, accounting for leases, accounting for income taxes and stock-based compensation and allowances for uncertainties. These factors are also influenced by regular changes to GAAP, some of which are material to most companies. These changes introduce risk to our financial reporting processes due to implementation and internal control implications.

We base the aforementioned estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as discussed in greater detail in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Our actual operating results may differ and fall below our assumptions and the financial forecasts of securities analysts and investors, resulting in a significant decline in our stock price.

Changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our results.

We are subject to the continuous examination of our income tax returns by the Internal Revenue Service, or IRS, and other tax authorities. It is possible that tax authorities may disagree with certain positions we have taken, and any adverse outcome of such a review or audit could have a negative effect on our financial position and operating results. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes, but the determination of our provision for income taxes and other tax liabilities requires significant judgment by management, and there are transactions where the ultimate tax determination is uncertain. Although we believe that our estimates are reasonable, the ultimate tax outcome may differ from the amounts recorded in our financial statements and may materially affect our financial results in the period or periods for which such determination is made. There can be no assurance that the outcomes from continuous examinations will not have an adverse effect on our business, financial condition, and results of operations.

We are subject to various privacy and consumer protection laws.

Our privacy policy is posted on our website, and any failure by us or our vendor or other business partners to comply with it or with federal, state or international privacy, data protection or security laws or regulations could result in regulatory or litigation-related actions against us, legal liability, fines, damages and other costs. Substantial expenses and operational changes may be required in connection with maintaining compliance with such laws, and in particular certain emerging privacy laws are still subject to a high degree of uncertainty as to their interpretation and application. For example, in May 2018, the General Data Protection Regulation (the “GDPR”) began to fully apply to the processing of personal information collected from individuals located in the European Union. The GDPR has created new compliance obligations and has significantly increased fines for noncompliance. Although we take steps to protect the security of our customers’ personal information, we may be required to expend significant resources to comply with data breach requirements if third parties improperly obtain and use the personal information of our customers or we otherwise experience a data loss with respect to customers’ personal information. A breach of our network security and systems could have negative consequences for our business and future prospects, including possible fines, penalties and damages, reduced customer demand for our products, and harm to our reputation and brand.

Political and economic uncertainty arising from the outcome of the United Kingdom’s referendum on its membership in the European Union could adversely affect our business and results of operations.

On June 23, 2016, the United Kingdom (“UK”) held a referendum in which voters approved a withdrawal from the European Union (“EU”), commonly referred to as “Brexit.” The United Kingdom officially withdrew from the EU on January 31, 2020. The terms of the withdrawal are subject to ongoing negotiation that has created significant uncertainty about the future relationship between the UK and the EU. It is possible that the level of economic activity in this region will be adversely impacted and that there will be increased regulatory and legal complexities, including those relating to tax, trade, security and employees. In addition, Brexit could lead to economic uncertainty, including significant volatility in global stock markets and currency exchange rates, which may adversely impact our business. Although the specific terms of the separation are unknown, it is possible that these changes could adversely affect our business and results of operations. To attempt to reduce the impact of a potential Brexit on our ability to sell our products in the EU, we have changed from a UK-based notified body, to notified bodies located within the EU.

Risks Related to Our Industry

We are subject to substantial government regulation that is subject to change and could force us to make modifications to how we develop, manufacture, market and price our products.

The medical device industry is regulated extensively by governmental authorities, principally the FDA in the U.S. and corresponding state and foreign regulatory agencies. The majority of our manufacturing processes are required to comply with quality systems regulations, including current good manufacturing practice requirements that cover the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging and shipping of our products. Failure to comply with applicable medical device regulatory requirements could result in, among other things, warning letters, fines, injunctions, civil penalties, repairs, replacements, refunds, recalls or seizures of products, total or partial suspensions of production, refusal of the FDA or other regulatory agencies to grant pre-market clearances or approvals for our products, withdrawals or suspensions of future or current clearances or approvals and criminal prosecution.

In addition, our products are subject to pre-clearance requirements by the FDA and similar international agencies that govern a wide variety of product activities from design and development to labeling, manufacturing, promotion, sales and distribution. Compliance with these regulations may be time consuming, burdensome and expensive for us. The failure to obtain, or the loss or suspension of any such pre-approval, would negatively affect our ability to sell our products and harm our anticipated revenues.

Foreign governmental authorities that regulate the manufacture and sale of medical devices have become increasingly stringent and, to the extent we sell our products in foreign countries, we may be subject to rigorous regulation in the future. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated revenue.

If we fail to obtain, or experience significant delays in obtaining, FDA clearances or other necessary approvals to commercially distribute new products, our ability to maintain profitability or grow will suffer.

Our current products are Class II medical devices and hence require regulatory pre-market approval by the FDA and other federal and state authorities prior to their sale in the U.S. Similar approvals are required by foreign governmental authorities for sale of our products outside of the U.S., including the EU. We are responsible for obtaining the applicable regulatory approval for the commercial distribution of our products. As part of our strategy, we plan to seek approvals for new MRI compatible products. The process of obtaining approvals is costly and time consuming, and there can be no assurance that we will obtain the required approvals on a timely basis, or at all. Failure to receive approvals for new products will hurt our ability to grow.

We are subject to risks associated with doing business outside of the U.S.

Sales to customers outside of the U.S. have historically comprised of approximately one-tenth to one-third of our net revenues and we expect that non-U.S. sales will contribute to future growth. A majority of our international sales originate from Europe and Japan, and we also make sales in Canada, Hong Kong, Australia, Mexico and certain parts of the Middle East. The risks associated with operations outside the U.S. include:

foreign regulatory and governmental requirements that could change and restrict our ability to manufacture and sell our products;

possible failure to comply with anti-bribery laws such as the U.S. Foreign Corrupt Practices Act and similar anti-bribery laws in other jurisdictions;

foreign currency fluctuations that can impact our financial statements when foreign denominations are translated into U.S. dollars;

different local product preferences and product requirements, which might increase with increasing nationalism;

trade protection and restriction measures under international trade treaties and via tariffs, and import or export licensing requirements;

difficulty in establishing, staffing and managing non-U.S. operations;

failure to maintain relationships with distributors, especially those who have assisted with foreign regulatory or government clearances;

changes in labor, environmental, health and safety laws;

potentially negative consequences from changes in or interpretations of tax laws, including U.S. state and foreign tax jurisdiction responses to recent changes in U.S. federal tax laws;

political instability and actual or anticipated military or political conflicts, including instability related to war and terrorist attacks and to political matters such as Brexit;

economic instability, inflation, deflation, recession or interest rate fluctuations;

uncertainties regarding judicial systems and procedures; and

minimal or diminished protection of intellectual property.

These risks, individually or in the aggregate, could have an adverse effect on our results of operations and financial condition.

We may incur product liability losses, or become subject to other lawsuits related to our products, business, and insurance coverage could be inadequate or unavailable to cover these losses.

Our business is subject to potential product liability risks that are inherent in the design, development, manufacture and marketing of our medical devices and consumable products. We carry third-party product liability insurance coverage to protect against such risks, but there can be no assurance that our policy is adequate. In the ordinary course of business, we may become the subject of product liability claims and lawsuits alleging that our products have resulted or could result in an unsafe condition or injury to patients. Any product liability claim brought against us, with or without merit, could be costly to defend and could result in settlement payments and adjustments not covered by or in excess of our product liability insurance. We currently have third-party product liability insurance with maximum coverage of $5,000,000; however, such coverage requires a substantial deductible that we must pay before becoming eligible to receive any insurance proceeds. The deductible amount is currently equal to $50,000 per occurrence and $150,000 in the aggregate. We will have to pay for defending product liability or other claims that are not covered by our insurance. These payments could have a material adverse effect on our profitability and financial condition. Product liability claims and lawsuits, safety alerts, recalls or corrective actions, regardless of their ultimate outcome, could have a material adverse effect on our business, financial condition, reputation and on our ability to attract and retain customers. In addition, we may not be able to obtain insurance in the future on terms acceptable to us or at all.

Defects or failures associated with our products and/or our quality control systems could lead to the filing of adverse event reports, recalls or safety alerts and negative publicity and could subject us to regulatory actions.

Safety problems associated with our products could lead to a product recall or the issuance of a safety alert relating to such products and result in significant costs and negative publicity. An adverse event involving one of our products could require us to file an adverse event report with the FDA. Such disclosure could result in reduced market acceptance and demand for all our products, and could harm our reputation and our ability to market our products in the future. In some circumstances, adverse events arising from or associated with the design, manufacture or marketing of our products could result in the suspension or delay of regulatory reviews of our applications for new product approvals or clearances.

We may also voluntarily undertake a recall of our products or temporarily shut down production lines based on internal safety, quality monitoring and testing data. To avoid future product recalls we have made and continue to invest in our quality systems, processes and procedures. We will continue to make improvements to our products and systems to further reduce issues related to patient safety.

However, there can be no assurance our efforts or systems will be sufficient. Future quality concerns, whether real or perceived, could adversely affect our operating results.

Our products or product types, or MR imaging could be subject to negative publicity, which could have a material adverse effect on our financial position and results of operations and could cause the market value of our common stock to decline.

The market’s perception of our products could be harmed if any of our products or similar products offered by others in our industry become the subject of negative publicity due to a product safety issue, withdrawal, recall, or are proven or are claimed to be harmful to patients. The harm to market perception may have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

Our products are designed for use around MRI scanners. MRI has been an important imaging diagnostic for some time now, however, should MRI technology change materially or decline in usage due to new technologies or concerns about costs or efficacy of MR imaging, our products would suffer as MRI usage and installations declined. Such a matter may also have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

U.S. healthcare policy and changes thereto, including the Patient Protection and Affordable Care Act, may have a material adverse effect on our financial condition and results of operations.

The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (collectively, the “PPACA”), enacted in 2010, implemented changes that significantly impacted the medical device industry. Beginning on January 1, 2013, the Affordable Care Act imposed a 2.3 percent excise tax on sales of products defined as “medical devices” by the regulations of the FDA. We believe that all our current products are “medical devices” within the meaning of the FDA regulations. On December 18, 2015, under the Consolidated Appropriations Act of 2015, the medical device excise tax was suspended for two years beginning on January 1, 2016. New legislation passed in January 2018 further suspended the medical device excise tax through December 31, 2019, however, in December 2019, the medical device excise tax was repealed. As a result of the repeal and the prior suspensions, sales of taxable medical devices after December 31, 2015 are not subject to the tax. While this tax has been repealed, Congress could enact future legislation or further change the law related to the medical devise excise tax in a manner that could negatively impact our operating results. The financial impact such future taxes could have on our business is unclear.

Other significant measures contained in the PPACA include research on the comparative clinical effectiveness of different technologies and procedures, initiatives to revise Medicare payment methodologies, such as bundling of payments across the continuum of care by providers and physicians, and initiatives to promote quality indicators in payment methodologies. The PPACA also includes significant new fraud and abuse measures, including required disclosures of financial payments to and arrangements with physician customers, lower thresholds for violations and increasing potential penalties for such violations.

Since its enactment, there have been judicial and Congressional challenges to certain aspects of the PPACA. In January 2017, Congress voted to adopt a budget resolution for fiscal year 2017, or the Budget Resolution, that authorizes the implementation of legislation that would repeal portions of the PPACA. The Budget Resolution is not a law; however, it was widely viewed as the first step toward the passage of legislation that would repeal certain aspects of the PPACA. Further, on January 20, 2017, President Trump signed an Executive Order directing federal agencies with authorities and responsibilities under the PPACA to waive, defer, grant exemptions from, or delay the implementation of any provision of the PPACA that would impose a fiscal or regulatory burden on states, individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. Additionally, the 2020 federal spending package permanently eliminated the PPACA-mandated “Cadillac” tax on high-cost employer-sponsored health coverage, effective January 2020 and the health insurance tax, effective January 2021. The potential impact of these efforts to repeal or defer and delay enforcement of the PPACA on our business remains unclear.

With enactment of the Tax Cuts and Jobs Act of 2017, in December 2017, Congress repealed the tax penalty associated with the “individual mandate” portion of the PPACA. The repeal of the penalty associated with this provision, which requires most Americans to carry a minimal level of health insurance, became effective in January 2019. Following the repeal of the tax penalty, in December 2019 the U.S. Court of Appeals for the 5th Circuit in Texas v. U.S. upheld a lower court ruling that the individual mandate in the PPACA is no longer constitutional, and the 5th Circuit court remanded the case back to the lower court for additional analysis on whether the remainder of the PPACA must be struck down as unconstitutional. In March 2020, the U.S. Supreme Court agreed to review the constitutionality of the individual mandate and the PPACA as a whole, granting certiorari in California v. Texas. A decision in this case is expected in 2021. Congress also could consider subsequent legislation to replace elements of the PPACA that are repealed. Because of the continued uncertainty about the implementation of the PPACA, including the outcome of California v. Texas and the potential for further legal challenges or repeal of the PPACA, we cannot quantify or predict with any certainty the likely impact of the PPACA or its repeal on our business, prospects, financial condition or results of operations.

We are subject to healthcare fraud and abuse regulations that could result in significant liability, require us to change our business practices and restrict our operations in the future.

We and our customers are subject to various U.S. federal, state and local laws targeting fraud and abuse in the healthcare industry, including anti-kickback and false claims laws. Violations of these laws are punishable by criminal or civil sanctions, including substantial fines, imprisonment and exclusion from participation in healthcare programs such as Medicare and Medicaid, and Veterans’ Administration health programs and health programs outside the U.S. These laws and regulations are broad in scope and are subject to evolving interpretations, which could require us to alter one or more of our sales or marketing practices. In addition, violations of these laws, or allegations of such violations, could disrupt our business and result in a material adverse effect on our sales, profitability and financial condition. Furthermore, since many of our customers rely on reimbursement from Medicare, Medicaid and other governmental programs to cover a substantial portion of their expenditures, if we or our customers are excluded from such programs as a result of a violation of these laws, it could have an adverse effect on our results of operations and financial condition.

We have developed and implemented business practices and processes to train our personnel to perform their duties in compliance with healthcare fraud and abuse laws and conduct informal oversight to detect and prevent these types of fraud and abuse. However, we lack formal written policies and procedures at this time. If we are unable to formally document and implement the controls and procedures required in a timely manner or we are otherwise found to be in violation of such laws, we might suffer adverse regulatory consequences or face criminal sanctions, which could harm our operations, financial reporting or financial results.

We could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws.

The U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws generally prohibit companies and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. We intend to adopt policies for compliance with these anti-bribery laws, which often carry substantial penalties.

We cannot assure you that our internal control policies and procedures always will protect us from reckless or other inappropriate acts committed by our affiliates, employees or agents. Violations of these laws, or allegations of such violations, could have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

We and our suppliers and customers are required to obtain regulatory approvals to comply with regulations applicable to medical devices and infusion pumps, and these approvals could result in delays or increased costs in developing new products.

In December 2014, the FDA issued guidance entitled “Infusion Pumps Total Product Life Cycle.” This guidance established substantial additional pre-market requirements for new and modified infusion pumps. Through this guidance, the FDA indicated more data demonstrating product safety will be required for future 510(k) submissions for infusion pumps, including the potential for more clinical and human factors data. The process for obtaining regulatory approvals to market infusion pumps and related accessories have become more costly and time consuming. The impact of this guidance is likely to result in a more time consuming and costly process to obtain regulatory clearance to market infusion pumps. In addition, new requirements could result in longer delays for the clearance of new products, modification of existing infusion pump products or remediation of existing products in the market. Future delays in the receipt of, or failure to obtain, approvals could result in delayed or no realization of product revenues.

We and our suppliers and customers are required to maintain compliance with regulations applicable to medical devices and infusion pumps, and it could be costly to comply with these regulations and to develop compliant products and processes. Failure to comply with these regulations could subject us to sanctions and could adversely affect our business.

Even if we are able to obtain approval for introducing new products to the market, we and our suppliers may not be able to remain in compliance with applicable FDA and other material regulatory requirements once clearance or approval has been obtained for a product. These requirements include, among other things, regulations regarding manufacturing practices, product labeling, off-label marketing, advertising and post-marketing reporting, adverse event reports and field alerts. Compliance with these FDA requirements is subject to continual review and is monitored through periodic inspections by the FDA. For example, the FDA conducted routine inspections of our facility in Winter Springs, Florida in July 2016. The FDA issued a Form 483 on July 18, 2016 resulting from an inspection of our facility between July 11 and July 18, 2016 that identified three observations. These observations were related to procedural and documentation issues associated with the CAPA system, vendor requirements and complaint investigation.

We submitted responses to the Form 483 in August 2016 and October 2016 in which we described our proposed corrective and preventative actions to address each of the observations. As part of our response, on October 13, 2016 we initiated a customer follow up to our August 2012 Safety Alert and made available an updated instruction card for customers. This Safety Alert was closed in August 2019.

In addition, manufacturing flaws, component failures, design defects, off-label uses or inadequate disclosure of product related information could result in an unsafe condition or the injury or death of a patient. All of these events could harm our sales, margins and profitability in the affected periods and may have a material adverse effect on our business. Any adverse regulatory action or action taken by us to maintain appropriate regulatory compliance, with respect to these laws and regulations could disrupt our business and have a material adverse effect on our sales, profitability and financial condition. Furthermore, an adverse regulatory action with respect to any of our products or operating procedures or to our suppliers’ manufacturing facilities could materially harm our reputation in the marketplace.

Our operations are subject to environmental laws and regulations, with which compliance is costly and which exposes us to penalties for non-compliance.

Our business, products, and product candidates are subject to federal, state, and local laws and regulations relating to the protection of the environment, worker health and safety and the use, management, storage, and disposal of hazardous substances, waste, and other regulated materials. These environmental laws and regulations could require us to pay for environmental remediation and response costs at third-party locations where we dispose of or recycle hazardous substances. The costs of complying with these various environmental requirements, as they now exist or as may be altered in the future, could adversely affect our financial condition and results of operations.

Risks Relating to our Intellectual Property

Our success depends on our ability to protect our intellectual property.

We intend to rely on a combination of patents, trademarks, trade secrets, know-how, license agreements and contractual provisions to establish and protect our proprietary rights to our technologies and products. We cannot guarantee that the steps we have taken or will take to protect our intellectual property rights will be adequate or that they will deter infringement, misappropriation or violation of our intellectual property. We may fail to secure patents that are important to our business, and we cannot guarantee that any pending U.S. trademark or patent application, if ultimately issued, will provide us some relative competitive advantage. Litigation may be necessary to enforce our intellectual property rights and to determine the validity and scope of our proprietary rights.

Any litigation could result in substantial expenses and may not adequately protect our intellectual property rights. In addition, the laws of some of the countries in which our products may in the future be sold may not protect our products and intellectual property to the same extent as U.S. laws, or at all. We may be unable to protect our rights in trade secrets and unpatented proprietary technology in these countries. If our trade secrets become known, we may lose our competitive advantages.

Even if we are able to secure necessary patents in the U.S., we may not be able to secure necessary patents and trademarks in foreign countries in which we sell our products or plan to sell our products. In 2013, the U.S. transitioned to a “first inventor to file” system for patents in which, assuming the other requirements for patentability are met, the first inventor to file a patent application is entitled to a patent. We may be subject to a third-party pre-issuance submission of prior art to the U.S. Patent and Trademark Office, or become involved in opposition, derivation, reexamination, inter parties review or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate our patent rights, allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third party patent rights.

Our unpatented trade secrets, know-how, confidential and proprietary information, and technology may be inadequately protected.

We rely on unpatented trade secrets, know-how and technology. This intellectual property is difficult to protect, especially in the medical device industry, where much of the information about a product must be submitted to regulatory authorities during the regulatory approval process. We seek to protect trade secrets, confidential information and proprietary information, in part, by entering into confidentiality and invention assignment agreements with employees, consultants, and others. These parties may breach or terminate these agreements, and we may not have adequate remedies for such breaches. Furthermore, these agreements may not provide meaningful protection for our trade secrets or other confidential or proprietary information or result in the effective assignment to us of intellectual property, and may not provide an adequate remedy in the event of unauthorized use or disclosure of confidential information or other breaches of the agreements. Despite our efforts to protect our trade secrets and our other confidential and proprietary information, we or our collaboration partners, board members, employees, consultants, contractors, or scientific and other advisors may unintentionally or willfully disclose our proprietary information to competitors.

There is a risk that our trade secrets and other confidential and proprietary information could have been, or could, in the future, be shared by any of our former employees with, and be used to the benefit of, any company that competes with us.

If we fail to maintain trade secret protection or fail to protect the confidentiality of our other confidential and proprietary information, our competitive position may be adversely affected. Competitors may also independently discover our trade secrets. Enforcement of claims that a third party has illegally obtained and is using trade secrets is expensive, time consuming and uncertain. If our competitors independently develop equivalent knowledge, methods and know-how, we would not be able to effectively assert our trade secret protections against them, which could have a material adverse effect on our business.

There can be no assurance of timely patent review and approval to minimize competition and generate sufficient revenues.

There can be no assurance that the Patent and Trademark Office will have sufficient resources to review our patent applications in a timely manner. Consequently, even if our patent applications are ultimately successful, our patent applications may be delayed, which would prevent intellectual property protection for our products. If we fail to successfully commercialize our products due to the lack of intellectual property protection, we may be unable to generate sufficient revenues to meet or grow our business according to our expected goals and this may have a materially adverse effect on our profitability, financial condition, and operations.

We may become involved in patent litigation or other intellectual property proceedings relating to our future product approvals, which could result in liability for damages or delay or stop our development and commercialization efforts.

The medical device industry has been characterized by significant litigation and other proceedings regarding patents, patent applications, and other intellectual property rights. The situations in which we may become parties to such litigation or proceedings may include any third parties (which may have substantially greater resources than we have) initiating litigation claiming that our products infringe their patent or other intellectual property rights; in such case, we will need to defend against such proceedings.

The large number of patents, the rapid rate of new patent applications and issuances, the complexities of the technologies involved and the uncertainty of litigation significantly increase the risks related to any patent litigation. Any potential intellectual property litigation also could force us to do one or more of the following:

stop selling, making, or using products that use the disputed intellectual property;

obtain a license from the intellectual property owner to continue selling, making, licensing, or using products, which license may require substantial royalty payments and may not be available on reasonable terms, or at all;

pay substantial damages or royalties to the party whose intellectual property rights we may be found to be infringing;

pay the attorney fees and costs of litigation to the party whose intellectual property rights we may be found to be infringing; or

redesign those products that contain the allegedly infringing intellectual property, which could be costly, disruptive and/or infeasible.

If any of the foregoing events occur, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our products, all of which could have a material adverse effect on our business, results of operations and financial condition. As the number of participants in our industry grows, the possibility of intellectual property infringement claims against us increases.

Furthermore, the costs of resolving any patent litigation or other intellectual property proceeding, even if resolved in our favor, could be substantial. Uncertainties resulting from the initiation and continuation of patent litigation or other intellectual property proceedings could have a material adverse effect on our ability to compete in the marketplace. Patent litigation and other intellectual property proceedings may also consume significant management time.

In the event that a competitor infringes upon our patent or other intellectual property rights, enforcing those rights may be costly, difficult, and time-consuming. Even if successful, litigation to enforce our intellectual property rights or to defend our patents against challenge could be expensive and time-consuming and could divert our management’s attention. We may not have sufficient resources to enforce our intellectual property rights or to defend our patent or other intellectual property rights against a challenge. If we are unsuccessful in enforcing and protecting our intellectual property rights and protecting our products, it could materially harm our business.

There may also be situations where we use our business judgment and decide to market and sell products, notwithstanding the fact that allegations of patent infringement(s) have not been finally resolved by the courts (i.e., an “at-risk launch”). The risk involved in doing so can be substantial because the remedies available to the owner of a patent for infringement may include, among other things, damages measured by the profits lost by the patent owner and not necessarily by the profits earned by the infringer. In the case of a willful infringement, the definition of which is subjective, such damages may be increased up to three times. An adverse decision could have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

In addition, we may indemnify our customers and distributors with respect to infringement by our products of the proprietary rights of third parties. Third parties may assert infringement claims against our customers or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers or distributors or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products.

We may be subject to claims that we, our board members, employees or consultants have used or disclosed alleged trade secrets or other proprietary information belonging to third parties and any such individuals who are currently affiliated with one of our competitors may disclose our proprietary technology or information.

As is commonplace in the medical device industry, some of our board members, employees and consultants are or have been associated with other medical device companies that compete with us. For example, Mr. Susi and a number of our other employees are former employees of Invivo Corporation and/or other medical device firms. While associated with such other companies, these individuals may have been exposed to research and technology similar to the areas of research, technology, sales methodology, pricing models and other such matters in which we are engaged. We may become subject to future claims that we, our employees, board members, or consultants have inadvertently or otherwise used or disclosed alleged trade secrets or other proprietary information of those companies. Litigation may be necessary to defend against such claims.

We have entered into confidentiality agreements with our executives and key consultants. However, we do not have, and are not planning to enter into, any confidentiality agreements with our non-executive directors because they have a fiduciary duty of confidentiality as directors.

There is the possibility that any of our former board members, employees, or consultants who are currently or who may be employed at, or associated with, one of our competitors may unintentionally or willfully disclose our proprietary technology or information.

Risks Related to Ownership of Our Common Stock

Our common stock price has been and will likely continue to be subject to significant fluctuations and volatility, and you may be unable to sell your shares at a fair price, or at all.

Our stock could be subject to wide fluctuations in price in response to various factors, including the following:

a lack of liquidity in the public trading of our common stock;

the commercial success or failure of our key products;

delayed or reduced orders from our customers;

manufacturing or supply interruptions;

changes or developments in laws or regulations applicable to our products and product candidates;

introduction of competitive products or technologies;

poorly executed acquisitions or acquisitions whose projected potential is not realized;

actual or anticipated variations in quarterly operating results;

failure to meet or exceed our own estimates and projections or the estimates and projections of securities analysts or investors;

new or revised earnings estimates or guidance by us or securities analysts or investors;

varying economic and market conditions in the U.S.;

negative developments impacting the medical device industry in general and changes in the market valuations of companies deemed similar to us;

negative developments concerning our sources of manufacturing supply;

disputes or other developments relating to patents, trademarks or other proprietary rights;

litigation or investigations involving us, our industry, or both;

issuances of debt, equity or convertible securities at terms deemed unfavorable by the market;

major catastrophic events;

sales of large blocks of our stock;

changes in our Board of Directors, management or key personnel; or

the other factors described in this “Risk Factors” section.

Any one of the factors above, or the cumulative effect of some of the factors referred to above, may result in significant fluctuations in our quarterly or annual operating results, fluctuations in our share price and investors’ perception of our business. If we fail to meet or exceed such expectations, our business and stock price could be materially adversely affected.

Any use of capital to repurchase shares of our common stock could have a material adverse effect on our stock price and our business.

Our Board of Directors has historically authorized stock repurchase programs and, pursuant to these authoriations, we have used a significant amount of cash to repurchase shares of common stock of our company. Historically, we have opportunistically repurchased additional shares of common stock from time to time at prices that we believe are attractive. While our stock repurchase program has expired, should our Board of Directors authorize another stock repurchase program, there can be no assurance that we will be able to repurchase shares on favorable terms or, if we do repurchase shares, that such repurchases will increase shareholder value. Additionally, if we use a significant portion of our capital to repurchase shares, our financial flexibility will be reduced, and we may not be able to execute on other strategic initiatives or tolerate periods of operating losses. If we repurchase shares on unfavorable terms or if our use of capital to repurchase shares inhibits our ability to pursue other strategic initiatives or tolerate periods of operating losses, it could have a material adverse effect on our stock price and our business.

We may need or choose to raise additional capital in the future, which could result in dilution to our stockholders and adversely affect stock price.

While we believe that our cash and investment balances and prospective cash flow from our operations will provide us with adequate capital to fund operations for at least the next 12 months from the date of the issuance of the financial statements included herein, we may need or choose to raise additional funds prior to that time. We may seek to sell additional equity or debt securities or to obtain a credit facility, which we may not be able to do on favorable terms, or at all. The sale of additional equity or convertible debt securities could result in additional dilution to our stockholders. If additional funds are raised through the issuance of debt securities or preferred stock, these securities could have rights that are senior to holders of common stock and any debt securities could contain covenants that would restrict our operations. The sale of such securities could hurt demand for our common stock and lead our share price to decline.

Roger Susi, who serves as our Chairman of the Board of Directors and Chief Technology Officer, owns a significant percentage of our stock and will be able to exert significant influence over matters subject to stockholder approval.

Mr. Susi, our founder, who serves as our Chairman of the Board of Directors, Chief Technology Officer, and his affiliates, beneficially owns a significant percentage of our outstanding common stock. Mr. Susi may be able to significantly influence matters requiring approval by our stockholders, including the election of directors and the approval of mergers, acquisitions or other extraordinary transactions. He may also have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This concentration of ownership may have the effect of delaying or deterring a change of control of our company.

We do not intend to pay dividends for the foreseeable future.

We do not anticipate that we will pay any cash dividends on shares of our common stock for the foreseeable future. Any determination to pay dividends in the future will be at the discretion of our Board of Directors and will depend upon results of operations, financial condition, contractual restrictions, restrictions imposed by applicable law and other factors our Board of Directors deems relevant. Investors seeking cash dividends should not purchase our common stock.

Accordingly, if you purchase shares, realization of a gain on your investment will depend solely on the appreciation of the price of our common stock, which may never occur.

The requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain executive management and qualified board members.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (“Exchange Act”), the Sarbanes-Oxley Act, the Dodd-Frank Act, the listing requirements of the Nasdaq Stock Market and other applicable securities rules and regulations. Pursuant to Section 404 of the Sarbanes-Oxley Act, our independent registered public accounting firm is required to deliver an attestation report on the effectiveness of our internal control over financial reporting. Compliance with these rules and regulations will increase our legal and financial compliance costs, make some activities more difficult, time-consuming or costly and increase demand on our systems and resources. The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and operating results. As a result, management’s attention may be diverted from other business concerns, which could adversely affect our business and operating results. We may need to hire more employees in the future or engage outside consultants to monitor and advise us regarding compliance, which will increase our costs and expenses.

In addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We are investing additional resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us, and our business may be adversely affected.

We believe that being a public company and compliant with these new rules and regulations has made it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members of our Board of Directors, particularly to serve on our audit committee and compensation committee, and qualified executive officers.

As a result of being a public company, we are obligated to establish and maintain adequate internal controls. Failure to develop and maintain adequate internal controls or to implement new or improved controls could have a material adverse effect on our business, financial position and results of operations and could cause the market value of our common stock to decline.

Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort. Our internal controls over financial reporting are designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. During the evaluation and testing process, if we identify one or more material weaknesses in our internal controls over financial reporting, we will be unable to assert that our internal controls are effective.

We are required to disclose changes made in our internal controls and procedures on a quarterly basis. Our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our controls are documented, designed or operating. Our remediation efforts may not enable us to avoid a material weakness in the future.

Our business practices have become more visible as a public company, and this could impact our competitive environment and our risk of potential litigation.

As a result of disclosure of information in filings required of a public company, our business and financial condition have become more visible potentially exposing us to new competition and threatened or actual litigation, including by competitors and other third parties. New competition could result in reduced sales of our products and adversely impact our profitability. If lawsuits prevail against us, our business and operating results could be adversely affected, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and adversely affect our business and operating results.

We may and have become involved in securities class action litigation that could divert management’s attention from our business and adversely affect our business and could subject us to significant liabilities.

The stock markets have from time to time experienced significant price and volume fluctuations that have affected the market prices of small capitalization medical device companies. These broad market fluctuations as well a broad range of other factors, including the realization of any of the risks described in this “Risk Factors” section, may cause the market price of our common stock to decline. In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. We have become, and may in the future, become involved in this type of litigation. Litigation is expensive and could divert management’s attention and resources from our primary business, which could adversely affect our operating results. Any adverse determination in any such litigation or any amounts paid to settle any such actual or threatened litigation could require us to make significant payments. Such payment could have a material impact on how investors view our company and result in a decline in our stock price.

If securities or industry analysts fail to initiate research coverage of our stock, downgrade our stock, or discontinue coverage, our trading volume might be reduced and our stock price could decline.

The trading market for our common stock depends, in part, on the research reports that securities or industry analysts publish about our business. If securities or industry analysts do not commence or continue coverage of our company, the trading market for our stock may not be robust and the price of our stock could likely be negatively impacted. In the event securities or industry analysts initiate coverage, and later downgrade our stock or discontinue such coverage, our stock price could decline.

Our charter documents and Delaware law have provisions that may discourage an acquisition of us by others and may prevent attempts by our stockholders to replace or remove our current management.

Provisions in our charter documents, as well as provisions of the Delaware General Corporation Law (“DGCL”), could depress the trading price of our common stock by making it more difficult for a third party to acquire us at a price favorable to our shareholders. These provisions include:

authorizing the issuance of “blank check” preferred stock, the terms of which may be established and shares of which may be issued without stockholder approval to defend against a takeover attempt; and

establishing advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted upon at stockholder meetings.

In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our Board of Directors. We are subject to Section 203 of the DGCL, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with an interested stockholder for a period of three years following the date on which the stockholder became an interested stockholder, unless such transactions are approved by our Board of Directors. This provision could have the effect of delaying or preventing a change of control, whether or not it is desired by or beneficial to our stockholders, which could also affect the price that some investors are willing to pay for our common stock.

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds

Not Applicable.

Item 3. Default Upon Senior Securities

Not Applicable.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information

Not Applicable.

Item 6. Exhibits

Exhibit Number		Description of Document
31.1		Certification of Chief Executive Officer pursuant to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer pursuant to Exchange Act Rule, 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 I.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**		XBRL Instance Document
101.SCH**		XBRL Taxonomy Extension Schema Document
101.CAL**		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF**		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB**		XBRL Taxonomy Extension Label Linkbase Document
101.PRE**		XBRL Taxonomy Extension Presentation Linkbase Document

This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

In accordance with Rule 402 of Regulation S-T, this interactive data file is deemed not filed or part of this Quarterly Report on Form 10-Q for purposes of Sections 11 or 12 of the Securities Act or Section 18 of the Exchange Act and otherwise is not subject to liability under these sections.

IRADIMED CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IRADIMED CORPORATION

Dated: May 7, 2020	/s/ Leslie McDonnell
	By:	Leslie McDonnell
	Its:	Chief Executive Officer and President (Principal Executive Officer and Authorized Officer)

	/s/ Chris Scott
	By:	Chris Scott
	Its:	Chief Financial Officer and Secretary (Principal Financial and Accounting Officer)

EX-31.1 2 tm2014488d1_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

Certification of Chief Executive Officer pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Leslie McDonnell, certify that:

I have reviewed this quarterly report on Form 10-Q of IRADIMED CORPORATION;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2020

/s/ Leslie McDonnell
By: Leslie McDonnell
Chief Executive Officer and President
(Principal Executive Officer)

EX-31.2 3 tm2014488d1_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

Certification of Chief Financial Officer pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Chris Scott, certify that:

I have reviewed this quarterly report on Form 10-Q of IRADIMED CORPORATION;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 7, 2020

/s/ Chris Scott
By: Chris Scott
Chief Financial Officer and Secretary
(Principal Financial and Accounting Officer)

EX-32.1 4 tm2014488d1_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of IRADIMED CORPORATION (the “Company”) on Form 10-Q for the quarter ending March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Leslie McDonnell
By: Leslie McDonnell
Chief Executive Officer and President
(Principal Executive Officer)
May 7, 2020


/s/ Chris Scott
By: Chris Scott
Chief Financial Officer and Secretary
(Principal Financial and Accounting Officer)
May 7, 2020

EX-101.INS 5 irmd-20200331.xml XBRL INSTANCE DOCUMENT 0001325618 us-gaap:RetainedEarningsMember 2020-03-31 0001325618 us-gaap:CommonStockMember 2020-03-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001325618 us-gaap:RetainedEarningsMember 2019-12-31 0001325618 us-gaap:CommonStockMember 2019-12-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001325618 us-gaap:RetainedEarningsMember 2019-03-31 0001325618 us-gaap:CommonStockMember 2019-03-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001325618 us-gaap:RetainedEarningsMember 2018-12-31 0001325618 us-gaap:CommonStockMember 2018-12-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001325618 us-gaap:EmployeeStockOptionMember 2019-12-31 0001325618 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001325618 irmd:InternationalMember 2020-01-01 2020-03-31 0001325618 country:US 2020-01-01 2020-03-31 0001325618 irmd:InternationalMember 2019-01-01 2019-03-31 0001325618 country:US 2019-01-01 2019-03-31 0001325618 irmd:InternationalMember 2020-03-31 0001325618 country:US 2020-03-31 0001325618 irmd:InternationalMember 2019-12-31 0001325618 country:US 2019-12-31 0001325618 us-gaap:MachineryAndEquipmentMember 2020-03-31 0001325618 us-gaap:LeaseholdImprovementsMember 2020-03-31 0001325618 us-gaap:FurnitureAndFixturesMember 2020-03-31 0001325618 irmd:ToolingInProcessMember 2020-03-31 0001325618 irmd:ComputerSoftwareAndHardwareMember 2020-03-31 0001325618 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001325618 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001325618 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001325618 irmd:ToolingInProcessMember 2019-12-31 0001325618 irmd:ComputerSoftwareAndHardwareMember 2019-12-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001325618 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001325618 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001325618 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001325618 us-gaap:TrademarksMember 2020-03-31 0001325618 irmd:SoftwareDevelopmentInUseMember 2020-03-31 0001325618 irmd:SoftwareDevelopmentInProcessMember 2020-03-31 0001325618 irmd:PatentsInUseMember 2020-03-31 0001325618 irmd:PatentsInProcessMember 2020-03-31 0001325618 us-gaap:TrademarksMember 2019-12-31 0001325618 irmd:SoftwareDevelopmentInUseMember 2019-12-31 0001325618 irmd:SoftwareDevelopmentInProcessMember 2019-12-31 0001325618 irmd:PatentsInUseMember 2019-12-31 0001325618 irmd:PatentsInProcessMember 2019-12-31 0001325618 us-gaap:RestrictedStockUnitsRSUMember 2020-03-31 0001325618 us-gaap:EmployeeStockOptionMember 2020-03-31 0001325618 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0001325618 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0001325618 us-gaap:ForeignCorporateDebtSecuritiesMember 2020-01-01 2020-03-31 0001325618 us-gaap:DomesticCorporateDebtSecuritiesMember 2020-01-01 2020-03-31 0001325618 us-gaap:ForeignCorporateDebtSecuritiesMember 2019-01-01 2019-12-31 0001325618 us-gaap:DomesticCorporateDebtSecuritiesMember 2019-01-01 2019-12-31 0001325618 2018-12-31 0001325618 2019-01-01 2019-12-31 0001325618 us-gaap:ForeignCorporateDebtSecuritiesMember 2020-03-31 0001325618 us-gaap:DomesticCorporateDebtSecuritiesMember 2020-03-31 0001325618 us-gaap:ForeignCorporateDebtSecuritiesMember 2019-12-31 0001325618 us-gaap:DomesticCorporateDebtSecuritiesMember 2019-12-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignCorporateDebtSecuritiesMember 2020-03-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DomesticCorporateDebtSecuritiesMember 2020-03-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignCorporateDebtSecuritiesMember 2020-03-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DomesticCorporateDebtSecuritiesMember 2020-03-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignCorporateDebtSecuritiesMember 2019-12-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DomesticCorporateDebtSecuritiesMember 2019-12-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignCorporateDebtSecuritiesMember 2019-12-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DomesticCorporateDebtSecuritiesMember 2019-12-31 0001325618 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001325618 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001325618 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-03-31 0001325618 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-03-31 0001325618 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-03-31 0001325618 us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0001325618 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-03-31 0001325618 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-03-31 0001325618 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-03-31 0001325618 us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0001325618 2019-03-31 0001325618 2017-12-31 0001325618 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001325618 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001325618 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001325618 irmd:MriCompatiblePatientVitalSignsMonitoringSystemsMember 2020-01-01 2020-03-31 0001325618 irmd:MRICompatibleIVInfusionPumpsMember 2020-01-01 2020-03-31 0001325618 irmd:MriCompatiblePatientVitalSignsMonitoringSystemsMember 2019-01-01 2019-03-31 0001325618 irmd:MRICompatibleIVInfusionPumpsMember 2019-01-01 2019-03-31 0001325618 irmd:WinterSpringsFloridaFacilityMember irmd:SusiLLCMember 2014-01-31 0001325618 irmd:WinterSpringsFloridaFacilityMember irmd:SusiLLCMember 2020-01-01 2020-03-31 0001325618 irmd:WinterSpringsFloridaFacilityMember irmd:SusiLLCMember 2014-01-01 2014-01-31 0001325618 2019-01-01 2019-03-31 0001325618 2020-03-31 0001325618 2019-12-31 0001325618 2020-05-01 0001325618 2020-01-01 2020-03-31 irmd:segment iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares false --12-31 Q1 2020 2020-03-31 10-Q 0001325618 12049978 Yes false Accelerated Filer IRADIMED CORPORATION false true 12765 35306 441557 461291 652564 492924 813298 779048 0 0 0 0 87446 -341 7924 101940 59738 P5Y P5Y P1Y P9Y2M12D 34133 1 5959362 4192754 1766608 5553537 2664834 2888703 2036674 2662713 4250 22345 456724 15 322160 19

993742

873332

7293303

5851843

596576

126826

1853838

1979780

-42192

-3998

30374

40807

19192394

19949639

382353

568958

382353

62524

219705

17993

82131

568958

58254

362152

17597

130955

69093

104547

22491

7123

62904

66728864

68367961

58963681

60510596

2768287

2287809

480478

2287809

480478

2782162

2304028

478134

2304028

478134

2768287

2287809

480478

2782162

2304028

478134

22713

28169

352250

412863

43481781

44636348

28027688

29684457

43481781

44636348

1656769

1154567

<div> <div> 13 — Commitments and Contingencies   Purchase commitments. We had various purchase orders for goods or services totaling $3,631,996 and $3,208,174 as of March 31, 2020 and December 31, 2019, respectively. No amounts related to these purchase orders have been recognized in our balance sheet.   Legal matters. We may from time to time become party to various legal proceedings or claims that arise in the ordinary course of business.   <div /></div> </div>

0.0001

31500000

11765875

11970937

11765875

11970937

1177

1197

1883759

1779644

<div> <div> 9 — Accumulated Other Comprehensive Income   The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2020 and 2019 are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized (Losses)  </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains on </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Available-For-Sale </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Securities </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at December 31, 2019 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 30,374 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gains on available-for-sale securities, net </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 10,433 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Reclassification realized in net earnings </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at March 31, 2020 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 40,807 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at December 31, 2018 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (42,192) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Gains on available-for-sale securities, net </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 35,317 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Reclassification realized in net earnings </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,877 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at March 31, 2019 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (3,998) </td> </tr> </table></div>   <div /></div> </div>

<div> <div> Our contract liabilities consist of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Advance payments from customers </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 35,306 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 12,765 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Shipments in-transit </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 22,345 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,250 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Extended warranty agreements </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4,530,360 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4,284,872 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,588,011 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,301,887 </td> </tr> </table></div>   Changes in the contract liabilities during the periods presented are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Deferred </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Revenue </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Contract liabilities, December 31, 2019 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4,301,887 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Increases due to cash received from customers </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 779,048 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Decreases due to recognition of revenue </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (492,924) </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contract liabilities, March 31, 2020 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,588,011 </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Deferred  </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Revenue </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Contract liabilities, December 31, 2018 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,605,789 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Increases due to cash received from customers </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 813,298 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Decreases due to recognition of revenue </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (652,564) </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contract liabilities, March 31, 2019 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,766,523 </td> </tr> </table></div>   <div /></div> </div>

3605789

3766523

4301887

4588011

1671420

1814209

2630467

2773802

2047827

2213730

<div> <div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="10" valign="bottom" style="width:46.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Losses </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,258,686 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 45,342 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,304,028 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 471,139 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 6,995 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 478,134 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,729,825 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 52,337 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,782,162 </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="10" valign="bottom" style="width:46.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31, 2019 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Losses </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,258,686 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 29,123 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,287,809 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 471,139 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 9,339 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 480,478 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,729,825 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 38,462 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,768,287 </td> </tr> </table></div>   <div /></div> </div>

2768287

2782162

38462

29123

9339

52337

45342

6995

1663415

1692445

124341

126308

387081

344784

<div> <div>   Revenue information by geographic region is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 6,322,106 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,073,735 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> International </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,355,435 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,363,858 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,677,541 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,437,593 </td> </tr> </table></div>   Revenue information by type is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Devices: </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> MRI compatible IV infusion pump system </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,664,834 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,192,754 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> MRI compatible patient vital signs monitoring systems </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,888,703 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,766,608 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total Devices revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,553,537 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,959,362 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Disposables, services and other </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,662,713 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,036,674 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Amortization of extended warranty agreements </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 461,291 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 441,557 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,677,541 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,437,593 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> 10 — Stock-Based Compensation   Stock-based compensation was recognized as follows in the Condensed Statements of Operations:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:25.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Cost of revenue </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 58,254 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 62,524 </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> General and administrative </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 362,152 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 219,705 </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Sales and marketing </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 130,955 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 82,131 </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Research and development </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 17,597 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 17,993 </td> </tr> <tr> <td valign="bottom" style="width:72.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 568,958 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 382,353 </td> </tr> </table></div>   As of March 31, 2020, we had $500,552 of unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of 3.4 years. As of March 31, 2020, we had $4,805,263 of unrecognized compensation cost related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of 3.1 years.   The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2020 (shares):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Stock </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Restricted </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Stock Units </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding beginning of period </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 638,860 </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 297,048 </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Awards granted </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> — </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 18,129 </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Awards exercised/vested </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (190,540) </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (19,844) </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Awards canceled </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (500) </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (25,724) </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding end of period </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 447,820 </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 269,609 </td> </tr> </table></div>   <div /></div> </div>

0.17

0.15

0.14

<div> <div> 3 — Basic and Diluted Net Income per Share   Basic net income per share is based upon the weighted-average number of common shares outstanding during the period. Diluted net income per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. Stock options and restricted stock units granted by us represent the only dilutive effect reflected in diluted weighted-average shares outstanding.   The following table presents the computation of basic and diluted net income per share:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:28.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended March 31, </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:28.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Net income </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,769,211 </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,845,565 </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Weighted-average shares outstanding — Basic </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 11,891,428 </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 11,029,639 </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Effect of dilutive securities: </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Underwriters’ warrants </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 99,814 </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Stock options </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 414,439 </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 996,303 </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Restricted stock units </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 59,738 </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 101,940 </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Weighted-average shares outstanding — Diluted </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 12,365,605 </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 12,227,696 </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Basic net income per share </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.15 </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.17 </td> </tr> <tr> <td valign="bottom" style="width:68.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Diluted net income per share </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 0.14 </td> <td valign="bottom" style="width:02.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 0.15 </td> </tr> </table></div>   Stock options and restricted stock units excluded from the calculation of diluted net income per share because the effect would have been anti-dilutive are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:70.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:26.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:70.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:26.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:70.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:70.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:26.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:70.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Anti-dilutive stock options and restricted stock units </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 62,904 </td> <td valign="bottom" style="width:02.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,123 </td> </tr> </table></div>   <div /></div> </div>

-0.149

-1.117

2166209

1623375

P3Y4M24D

P3Y1M6D

500552

4805263

4284872

4530360

<div> <div> 8 — Fair Value Measurements   The fair values of cash equivalents, accounts receivables, net and accounts payable approximate their carrying amounts due to their short duration.   The fair value of our assets and liabilities subject to recurring fair value measurements are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="11" valign="bottom" style="width:47.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value at March 31, 2020 </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> in Active </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Other </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Market for </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Identical Assets </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,304,028 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,304,028 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 478,134 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 478,134 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,782,162 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,782,162 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="11" valign="bottom" style="width:47.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value at December 31, 2019 </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> in Active </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Other </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Market for </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Identical Assets </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,287,809 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,287,809 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 480,478 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 480,478 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,768,287 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,768,287 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   Our corporate bonds are valued by a third-party custodian at closing prices from secondary exchanges or pricing vendors on the valuation date.   There were no transfers into or out of any Levels during the three months ended March 31, 2020 or the year ended December 31, 2019. <div /></div> </div>

539187

561678

67472

88439

88740

89392

89963

1399274

120581

304270

80721

867569

26133

1463056

139641

304270

124808

867569

26768

860087

901378

2412696

2862727

6389766

6463811

1606419

835737

<div> <div> 11 — Income Taxes   For the three months ended March 31, 2020, we recorded a provision for income tax benefit of $(933,474). Our effective tax rate was (111.7) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation and a U.S. state tax benefit. Additionally, we recognized a benefit in our effective tax rate resulting from the Coronavirus Aid, Relief, and Economic Security Act, which allowed us to carryback the net operating loss to years prior to the enactment of the Tax Cuts and Jobs Act.   For the three months ended March 31, 2019, we recorded a provision for income tax benefit of  $(239,146). Our effective tax rate was (14.9) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation, partially offset by U.S. state tax expense.   As of March 31, 2020 and December 31, 2019, we had not identified or accrued for any uncertain tax positions. We are currently unaware of any uncertain tax positions that could result in significant payments, accruals or other material deviations in this estimate over the next 12 months. We believe that our tax positions comply in all material respects with applicable tax law. However, tax law is subject to interpretation, and interpretations by taxing authorities could be different from ours, which could result in the imposition of additional taxes and penalties.   We file tax returns in the United States Federal jurisdiction and many U.S. state jurisdictions. The Company is subject to income tax examinations for our United States Federal and certain U.S. state income taxes for 2016 and subsequent years and various other U.S. state income taxes for 2015 and subsequent years.   <div /></div> </div>

-239146

-933474

375202

-266644

1140008

-1404704

-298094

-901001

338078

308559

-59048

32472

-378354

-542834

333546

560996

4891

60614

665862

538093

-46832

-469750

99814

996303

414439

<div> <div> 6 — Intangible Assets   The following table summarizes the components of intangible asset balances:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents — in use </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 304,270 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 304,270 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Patents — in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 139,641 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 120,581 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Internally developed software — in use </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 867,569 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 867,569 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Internally developed software — in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 124,808 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 80,721 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Trademarks </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 26,768 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 26,133 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,463,056 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,399,274 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated amortization </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (561,678) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (539,187) </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 901,378 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 860,087 </td> </tr> </table></div>   Amortization expense of intangible assets was $22,491  for the three months ended March 31, 2020 and 2019.   Expected annual amortization expense for the remaining portion of 2020 and the next five years related to intangible assets is as follows (excludes in process intangible assets):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Nine months ending December 31, 2020 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 67,472 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 89,963 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2022 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 89,392 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2023 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 88,740 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2024 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 88,439 </td> </tr> <tr> <td valign="bottom" style="width:84.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2025 </td> <td valign="bottom" style="width:02.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 87,446 </td> </tr> </table></div>   <div /></div> </div>

224852

228718

<div> <div> 4 — Inventory   Inventory consists of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Raw materials </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,513,972 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,939,451 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Work in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 282,198 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 229,479 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Finished goods </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 647,509 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 697,483 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Inventory before allowance for excess and obsolete </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,443,679 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,866,413 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Allowance for excess and obsolete </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (228,718) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (224,852) </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,214,961 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,641,561 </td> </tr> </table></div>   <div /></div> </div>

697483

647509

3866413

4443679

3641561

4214961

2939451

3513972

229479

282198

120529

128143

<div> <div> 7 — Investments   Our investments consist of corporate bonds that we have classified as available-for-sale and are summarized in the following tables:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="10" valign="bottom" style="width:46.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, 2020 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Losses </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,258,686 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 45,342 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,304,028 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 471,139 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 6,995 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 478,134 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,729,825 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 52,337 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,782,162 </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="10" valign="bottom" style="width:46.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31, 2019 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gross </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Cost </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Losses </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,258,686 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 29,123 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,287,809 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 471,139 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 9,339 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 480,478 </td> </tr> <tr> <td valign="bottom" style="width:50.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,729,825 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 38,462 </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,768,287 </td> </tr> </table></div>   <div /></div> </div>

false

3754631

1809050

409596

307197

857624

<div> <div> 12 — Leases   We have only one material lease contract outstanding. In January 2014, we entered into a non-cancelable operating lease, commencing July 1, 2014, for our manufacturing and headquarters facility in Winter Springs, Florida owned by Susi, LLC, an entity controlled by our Chairman of the Board and Chief Technology Officer, Roger Susi. Pursuant to the terms of our lease for this property, the monthly base rent is $34,133, adjusted annually for changes in the consumer price index. Under the terms of the lease, we are responsible for property taxes, insurance and maintenance expenses. Prior to May 31, 2019, the expiration date of the initial lease term, and pursuant to the terms of the lease contract, we renewed the lease for an additional five years, resulting in a new lease expiration date of May 31, 2024. Unless advance written notice of termination is timely provided, the lease will automatically renew for one additional successive term of five years beginning in 2024, and thereafter, will be renewed for successive terms of one year each. For purposes of Topic 842, we concluded that we will exercise both of the five-year options, resulting in a remaining lease term of 9.2 years as of March 31, 2020. This lease agreement does not contain any residual value guarantee or material restrictive covenants.   Operating lease cost recognized in the Condensed Statements of Operations is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:27.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:27.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, </td> </tr> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Cost of revenue </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 46,535 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 46,535 </td> </tr> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> General and administrative </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 46,044 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 46,044 </td> </tr> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Sales and marketing </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,604 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,605 </td> </tr> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Research and development </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 7,215 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 7,215 </td> </tr> <tr> <td valign="bottom" style="width:70.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 102,398 </td> <td valign="bottom" style="width:02.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 102,399 </td> </tr> </table></div>   Lease costs for short-term leases were immaterial for the three months ended March 31, 2020.   Maturity of Operating Lease Liability as of March 31, 2020 is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Nine months ending December 31, 2020 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 307,197 </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 409,596 </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2022 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 409,596 </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2023 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 409,596 </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2024 </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 409,596 </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Thereafter </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,809,050 </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total lease payments </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,754,631 </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Imputed interest </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (857,624) </td> </tr> <tr> <td valign="bottom" style="width:84.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Present value of lease liability </td> <td valign="bottom" style="width:02.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,897,007 </td> </tr> </table></div>   <div /></div> </div>

11204469

10306657

66728864

68367961

5858972

4880322

<div> <div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,757,458 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,689,740 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> International </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 342,320 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 364,066 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total property and equipment, net </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,099,778 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,053,806 </td> </tr> </table></div>   <div /></div> </div>

434232

188307

557333

-230375

665204

1196635

1845565

1769211

<div> <div> Recent Accounting Pronouncements   Recently Issued Accounting Pronouncements to be Implemented   In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 will be effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We do not expect ASU 2019-12 to have a material impact on financial condition, results of operations or cash flows.   In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. In November 2018, April 2019 and May 2019, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses and ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, which provided additional implementation guidance on ASU 2016-03. The previously mentioned ASUs are effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We do not expect the adoption of these ASUs to have a material impact on our financial condition, results of operations or cash flows. <div /></div> </div>

92574

98502

4875921

5726576

1513845

737235

102399

46535

46044

7215

2605

102398

46535

46044

7215

2604

2897007

240843

244474

2715030

2652533

106659

107081

2955873

2897007

<div> <div> IRADIMED CORPORATION Notes to Unaudited Condensed Financial Statements   1 — Basis of Presentation   The accompanying interim condensed financial statements of IRADIMED CORPORATION (“IRADIMED”, the “Company”, “we”, “our”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally presented in annual financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to such rules and regulations. The interim financial information is unaudited, but reflects all normal adjustments that are, in the opinion of management, necessary for the fair presentation of our financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.   These accompanying interim condensed financial statements should be read with the financial statements and related footnotes to financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019. The accounting policies followed in the preparation of these interim condensed financial statements, except as described in Note 1, are consistent in all material respects with those described in Note 1 of our Form 10-K.   We operate in one reportable segment which is the development, manufacture and sale of MRI compatible medical devices, related accessories, disposables and services for use by hospitals and acute care facilities during MRI procedures.   Certain Significant Risks and Uncertainties   We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses.    COVID-19 Considerations   We are subject to risks and uncertainties as a result of the spread of COVID-19. The extent of the impact of COVID-19 on our business is highly uncertain and difficult to predict. Our future results of operations and liquidity could be adversely impacted by delays in payments, supply chain disruptions, and uncertain demand. As of the date of the issuance of these financial statements, the extent to which COVID-19 may materially impact our financial condition, liquidity, or results of operations in future periods is uncertain.   Recent Accounting Pronouncements   Recently Issued Accounting Pronouncements to be Implemented   In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 will be effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We do not expect ASU 2019-12 to have a material impact on financial condition, results of operations or cash flows.   In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. In November 2018, April 2019 and May 2019, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses and ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, which provided additional implementation guidance on ASU 2016-03. The previously mentioned ASUs are effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We do not expect the adoption of these ASUs to have a material impact on our financial condition, results of operations or cash flows. <div /></div> </div>

232002

266757

35317

10433

11656

3442

38194

10433

38194

10433

-2877

-949

108421

22507

133872

9724

63782

82943

166593

407802

753334

1370947

2271948

650000

456739

322179

81761

89685

1845565

1769211

<div> <div> 5 — Property and Equipment   Property and equipment consist of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Computer software and hardware </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 647,988 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 627,624 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Furniture and fixtures </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,117,693 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,112,550 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Leasehold improvements </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 225,841 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 225,841 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Machinery and equipment </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,796,394 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,778,524 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Tooling in-process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 291,642 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 163,105 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,079,558 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,907,644 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated depreciation </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (1,979,780) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (1,853,838) </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,099,778 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,053,806 </td> </tr> </table></div>   Depreciation expense of property and equipment was $126,308 and $124,341 for the three months ended March 31, 2020 and 2019, respectively.   Property and equipment, net, information by geographic region is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,757,458 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,689,740 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> International </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 342,320 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 364,066 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total property and equipment, net </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,099,778 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,053,806 </td> </tr> </table></div>   Long-lived assets held outside of the United States consist principally of tooling and machinery and equipment, which are components of property and equipment, net. <div /></div> </div>

3907644

627624

163105

1112550

225841

1778524

4079558

647988

291642

1117693

225841

1796394

2053806

1689740

364066

2099778

1757458

342320

21450

36756

3208174

3631996

-3826

2877

352573

430282

-22507

-133873

36300450

38069661

8437593

7073735

1363858

8677541

6322106

2355435

<div> <div> 2 — Revenue Recognition   Disaggregation of Revenue   We disaggregate revenue from contracts with customers by geographic region and revenue type as we believe it best depicts the nature, amount, timing and uncertainty of our revenue and cash flow.   Revenue information by geographic region is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 6,322,106 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,073,735 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> International </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,355,435 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,363,858 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,677,541 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,437,593 </td> </tr> </table></div>   Revenue information by type is as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Three Months Ended </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Devices: </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> MRI compatible IV infusion pump system </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,664,834 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,192,754 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> MRI compatible patient vital signs monitoring systems </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,888,703 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,766,608 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total Devices revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,553,537 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,959,362 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Disposables, services and other </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,662,713 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,036,674 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Amortization of extended warranty agreements </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 461,291 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 441,557 </td> </tr> <tr> <td valign="bottom" style="width:67.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total revenue </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,677,541 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8,437,593 </td> </tr> </table></div>   Contract Liabilities   Our contract liabilities consist of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Advance payments from customers </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 35,306 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 12,765 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Shipments in-transit </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 22,345 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,250 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Extended warranty agreements </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4,530,360 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4,284,872 </td> </tr> <tr> <td valign="bottom" style="width:67.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,588,011 </td> <td valign="bottom" style="width:02.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,301,887 </td> </tr> </table></div>   Changes in the contract liabilities during the periods presented are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Deferred </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Revenue </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Contract liabilities, December 31, 2019 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4,301,887 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Increases due to cash received from customers </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 779,048 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Decreases due to recognition of revenue </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (492,924) </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contract liabilities, March 31, 2020 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,588,011 </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Deferred  </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:15.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Revenue </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Contract liabilities, December 31, 2018 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,605,789 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Increases due to cash received from customers </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 813,298 </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Decreases due to recognition of revenue </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (652,564) </td> </tr> <tr> <td valign="bottom" style="width:81.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Contract liabilities, March 31, 2019 </td> <td valign="bottom" style="width:03.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,766,523 </td> </tr> </table></div>   Capitalized Contract Costs   Our capitalized contract costs consist of:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31, </td> </tr> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:64.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Capitalized contract costs </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.46%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 412,863 </td> <td valign="bottom" style="width:03.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 352,250 </td> </tr> </table></div>   Expense related to the amortization of capitalized contract costs was $28,169 and $22,713 for the three months ended March 31, 2020 and 2019, respectively. <div /></div> </div>

8437593

8677541

3182724

<div> <div>   The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2020 and 2019 are as follows:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unrealized (Losses)  </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Gains on </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Available-For-Sale </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:17.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Securities </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at December 31, 2019 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 30,374 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gains on available-for-sale securities, net </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 10,433 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Reclassification realized in net earnings </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at March 31, 2020 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 40,807 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Balance at December 31, 2018 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (42,192) </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Gains on available-for-sale securities, net </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 35,317 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Reclassification realized in net earnings </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:15.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,877 </td> </tr> <tr> <td valign="bottom" style="width:80.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Balance at March 31, 2019 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:15.86%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (3,998) </td> </tr> </table></div>   <div /></div> </div>

<div> <div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="11" valign="bottom" style="width:47.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value at March 31, 2020 </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> in Active </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Other </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Market for </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Identical Assets </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,304,028 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,304,028 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 478,134 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 478,134 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,782,162 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,782,162 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="11" valign="bottom" style="width:47.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair Value at December 31, 2019 </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Quoted Prices </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> in Active </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Other </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Significant </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Market for </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Observable </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Unobservable </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Fair </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Identical Assets </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Inputs </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 1) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 2) </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Corporate bonds: </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> U.S. corporations </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,287,809 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,287,809 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> International corporations </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 480,478 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 480,478 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:50.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,768,287 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,768,287 </td> <td valign="bottom" style="width:01.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> </table></div>   <div /></div> </div>

<div> <div> <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Patents — in use </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 304,270 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 304,270 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Patents — in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 139,641 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 120,581 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Internally developed software — in use </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 867,569 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 867,569 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Internally developed software — in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 124,808 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 80,721 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Trademarks </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 26,768 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 26,133 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,463,056 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,399,274 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accumulated amortization </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (561,678) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (539,187) </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 901,378 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 860,087 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2019 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> (unaudited) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Raw materials </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,513,972 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,939,451 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Work in process </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 282,198 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 229,479 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Finished goods </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 647,509 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 697,483 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Inventory before allowance for excess and obsolete </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,443,679 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,866,413 </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Allowance for excess and obsolete </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (228,718) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (224,852) </td> </tr> <tr> <td valign="bottom" style="width:65.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,214,961 </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,641,561 </td> </tr> </table></div>   <div /></div> </div>

<div> <div>   The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2020 (shares):   <div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 90.00%;margin-left:36pt;"> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Stock </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Restricted </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Stock Units </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding beginning of period </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 638,860 </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 297,048 </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Awards granted </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> — </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 18,129 </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Awards exercised/vested </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (190,540) </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> (19,844) </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Awards canceled </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (500) </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (25,724) </td> </tr> <tr> <td valign="bottom" style="width:73.56%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding end of period </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 447,820 </td> <td valign="bottom" style="width:02.32%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 269,609 </td> </tr> </table></div>   <div /></div> </div>

2110652

2433567

382353

568958

25724

18129

297048

269609

19844

500

638860

447820

-42192

15317335

1099

26669491

44646077

-3998

16133905

1114

28515056

55524395

30374

19192394

1177

36300450

58061304

40807

19949639

1197

38069661

190540

2729825

2258686

471139

2729825

2258686

471139

12227696

12365605

11029639

11891428

EX-101.SCH 6 irmd-20200331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Revenue Recognition - Information by Type (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Revenue Recognition - Contract Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Basic and Diluted Net Income per Share (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 41203 - Disclosure - Leases - Maturity of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 41203 - Disclosure - Leases - Maturity of lease liabilities (Details) Calc 2 link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Basic and Diluted Net Income per Share link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Basic and Diluted Net Income per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Revenue Recognition - Information by geographic region (Details) link:presentationLink link:calculationLink link:definitionLink 40204 - Disclosure - Revenue Recognition - Capitalized Contract Costs (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Property and Equipment - Geographic information (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Accumulated Other Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - Leases - Operating Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Revenue Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 irmd-20200331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 irmd-20200331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 irmd-20200331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information Statement [Table] Statement [Line Items] Statement Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Filer Category Entity Common Stock, Shares Outstanding Entity Small Business Entity Emerging Growth Company Entity Shell Company Document Fiscal Year Focus Document Fiscal Period Focus CONDENSED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable, net of allowance for doubtful accounts of $104,547 as of March 31, 2020 and $69,093 as of December 31, 2019 Debt Securities, Current Investments Inventory, Net Inventory, net Total Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Prepaid Taxes Prepaid income taxes Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Total Finite-Lived Intangible Assets, Net Intangible assets, net Total Operating Lease, Right-of-Use Asset Operating lease right-of-use asset Deferred Income Tax Assets, Net Deferred income taxes, net Other Assets, Noncurrent Other assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Employee-related Liabilities, Current Accrued payroll and benefits Accrual for Taxes Other than Income Taxes, Current Other accrued taxes Product Warranty Accrual, Current Warranty reserve Contract with Customer, Liability, Current Deferred revenue Operating Lease, Liability, Current Current portion of operating lease liability Other Liabilities, Current Other current liability Liabilities, Current Total current liabilities Contract with Customer, Liability, Noncurrent Deferred revenue Operating Lease, Liability, Noncurrent Operating lease liability, less current portion Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock; $0.0001 par value; 31,500,000 shares authorized; 11,970,937 shares issued and outstanding as of March 31, 2020 and 11,765,875 shares issued and outstanding as of December 31, 2019 Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Retained earnings Accumulated Other Comprehensive Income (Loss), Net of Tax Balance at the end Balance at the beginning Accumulated other comprehensive income Stockholders' Equity Attributable to Parent Balances Balances Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Allowance for Doubtful Accounts Receivable, Current Accounts receivable, allowance for doubtful accounts Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding STATEMENTS OF OPERATIONS Revenues Revenue Cost of Revenue. Cost of revenue Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: General and Administrative Expense General and administrative Selling and Marketing Expense Sales and marketing Research and Development Expense Research and development Operating Expenses Total operating expenses Operating Income (Loss) Income from operations Nonoperating Income (Expense) Other income, net Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income before provision for income taxes Income Tax Expense (Benefit) Provision for income tax benefit Net Income (Loss) Attributable to Parent Net income Net income Earnings Per Share, Basic [Abstract] Net income per share: Earnings Per Share, Basic Basic net income per share (in dollars per share) Basic (in dollars per share) Earnings Per Share, Diluted Diluted net income per share (in dollars per share) Diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Basic Weighted-average shares outstanding - Basic (in shares) Basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares outstanding - Diluted (in shares) Diluted (in shares) STATEMENTS OF COMPREHENSIVE INCOME Accumulated Other Comprehensive Income (Loss) Other comprehensive income: Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Change in fair value of available-for-sale securities, net of tax expense of $3,442 and $11,656, respectively Gains on available-for-sale securities, net Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Realized loss on available-for-sale securities reclassified to net income, net of tax benefit of $0 and $949, respectively Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent Change in fair value of available-for-sale securities, net of tax expense Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax Realized loss on available-for-sale securities reclassified to net income, net of tax expense (benefit) STATEMENTS OF STOCKHOLDERS' EQUITY Increase (Decrease) in Stockholders' Equity Other Comprehensive Income (Loss), Net of Tax Other comprehensive income Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation Restricted Stock, Value, Shares Issued Net of Tax Withholdings Net share settlement of restricted stock units Value of stock issued as a result of the exercise of stock options and warrants. Stock Issued During Period, Value, Stock Options And Warrants Exercised Exercise of stock options and warrants STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Provision for Doubtful Accounts Change in allowance for doubtful accounts Inventory Write-down Change in provision for excess and obsolete inventory Depreciation, Depletion and Amortization Depreciation and amortization Share-based Compensation Stock-based compensation Increase (Decrease) in Deferred Income Taxes Deferred income taxes, net Realized Investment Gains (Losses) Loss on maturities of investments Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Operating Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Employee Related Liabilities Accrued payroll and benefits Increase (Decrease) in Property and Other Taxes Payable Other accrued taxes Represents the increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to warranty reserve. Increase Decrease in Warranty Reserve Warranty reserve Increase (Decrease) in Contract with Customer, Liability Deferred revenue Increase (Decrease) in Income Taxes Payable Prepaid income taxes Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Investing activities: Proceeds from Sale, Maturity and Collection of Investments Proceeds from maturity of investments Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Payments to Acquire Other Productive Assets Capitalized intangible assets Net Cash Provided by (Used in) Investing Activities Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Financing activities: Proceeds from Stock Options Exercised Proceeds from stock option exercises Payments Related to Tax Withholding for Share-based Compensation Taxes paid for the net share settlement of equity awards Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-use asset recognized in exchange for new lease obligation Operating Lease, Payments Operating and short-term lease payments recorded within cash flow from operating activities Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Basis of Presentation Revenue Recognition Revenue from Contract with Customer [Text Block] Revenue Recognition Basic and Diluted Net Income per Share Earnings Per Share [Text Block] Basic and Diluted Net Income per Share Inventory Inventory Disclosure [Text Block] Inventory Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Property and Equipment Intangible Assets Intangible Assets Disclosure [Text Block] Intangible Assets Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Investments Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Comprehensive Income (Loss) Note [Text Block] Accumulated Other Comprehensive Income (Loss) Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation Income Taxes Income Tax Disclosure [Text Block] Income Taxes Leases Lessee, Operating Leases [Text Block] Leases Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Concentration Risk, Credit Risk, Policy [Policy Text Block] Certain Significant Risks and Uncertainties New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Disaggregation of Revenue [Table Text Block] Schedule of disaggregation of revenue by geographic region and revenue type Contract with Customer, Asset and Liability [Table Text Block] Schedule of contract liabilities and changes in the contract liabilities Capitalized Contract Cost [Table Text Block] Schedule of capitalized contract costs Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted net income per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of stock options and restricted stock units excluded from the calculation of diluted net income per share Schedule of Inventory, Current [Table Text Block] Schedule of inventory Property, Plant and Equipment [Table Text Block] Schedule of property and equipment Long-lived Assets by Geographic Areas [Table Text Block] Schedule of property and equipment, net, information by geographic region Schedule of Finite-Lived Intangible Assets [Table Text Block] Summary of the components of intangible asset balances Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of expected annual amortization expense related to intangible assets (excludes in process intangible assets) Debt Securities, Available-for-sale [Table Text Block] Summary of available-for-sale securities Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of the fair value of assets and liabilities subject to recurring fair value measurements Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of components of accumulated other comprehensive loss, net of tax Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of stock-based compensation Schedule of Share-based Compensation, Activity [Table Text Block] Summary of stock options and restricted stock units activity Lease, Cost [Table Text Block] Schedule of lease cost Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of maturity of lease liabilities Number of Reportable Segments Number of reportable segment Disaggregation of Revenue [Table] Contract Liabilities Disaggregation of Revenue Contract Liabilities Revenue from Contract with Customer, Excluding Assessed Tax Total revenue Total revenue Amount of revenue excluding tax, earned from contracts with customers before other income. Revenue from Contract with Customer Before Other Income, Excluding Assessed Tax Total Devices Revenue Amount of revenue earned from disposables and services. Revenue from Disposables and Services Disposables, services and other Amount of amortization of extended warranty agreements. Amortization of Extended Warranty Agreements Amortization of extended warranty agreements Deferred revenue Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. Advance Payments From Customers Advance payments from customers Amount of revenue recognized that was previously included in balance of obligation to shipments in-transit. Shipments in-Transit Shipments in-transit Extended Product Warranty Accrual Extended warranty agreements Contract With Customer Liability Contract liabilities at end of the year Contract liabilities at beginning of the year Total Changes in contract liabilities Amount of increase in contract liabilities due to cash received from customers. Contract with Customer, Liability, Increase Due to Cash Received from Customers Increases due to cash received from customers Amount of decrease in contract liabilities due to recognition of revenue. Contract with Customer, Liability, Decrease Due to Recognition of Revenue Decreases due to recognition of revenue Capitalized Contract Cost [Table] Capitalized Contract Cost [Line Items] Capitalized Contract Costs Capitalized Contract Cost, Net Capitalized contract costs Capitalized Contract Cost, Amortization Expense related to amortization of capitalized contract costs Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract] Effect of dilutive securities: Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Underwriters' warrants EX-101.PRE 10 irmd-20200331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R12.htm IDEA: XBRL DOCUMENT

Inventory

3 Months Ended

Mar. 31, 2020

Inventory

Inventory

4 — Inventory

Inventory consists of:


	March 31,		December 31,
	2020		2019
	(unaudited)
Raw materials	$	3,513,972	$	2,939,451
Work in process		282,198		229,479
Finished goods		647,509		697,483
Inventory before allowance for excess and obsolete		4,443,679		3,866,413
Allowance for excess and obsolete		(228,718)		(224,852)
Total	$	4,214,961	$	3,641,561

XML 12 R16.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Mar. 31, 2020

Fair Value Measurements

Fair Value Measurements

8 — Fair Value Measurements

The fair values of cash equivalents, accounts receivables, net and accounts payable approximate their carrying amounts due to their short duration.

The fair value of our assets and liabilities subject to recurring fair value measurements are as follows:


	Fair Value at March 31, 2020
			Quoted Prices		Significant
			in Active		Other		Significant
			Market for		Observable		Unobservable
	Fair		Identical Assets		Inputs		Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
Corporate bonds:
U.S. corporations	$	2,304,028	$	—	$	2,304,028	$	—
International corporations		478,134		—		478,134		—
Total	$	2,782,162	$	—	$	2,782,162	$	—


	Fair Value at December 31, 2019
			Quoted Prices		Significant
			in Active		Other		Significant
			Market for		Observable		Unobservable
	Fair		Identical Assets		Inputs		Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
Corporate bonds:
U.S. corporations	$	2,287,809	$	—	$	2,287,809	$	—
International corporations		480,478		—		480,478		—
Total	$	2,768,287	$	—	$	2,768,287	$	—

Our corporate bonds are valued by a third-party custodian at closing prices from secondary exchanges or pricing vendors on the valuation date.

There were no transfers into or out of any Levels during the three months ended March 31, 2020 or the year ended December 31, 2019.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 13 R35.htm IDEA: XBRL DOCUMENT

Revenue Recognition - Information by Type (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue
Total Devices Revenue	$ 5,553,537	$ 5,959,362
Disposables, services and other	2,662,713	2,036,674
Amortization of extended warranty agreements	461,291	441,557
Total revenue	8,677,541	8,437,593
MRI compatible IV infusion pump system
Disaggregation of Revenue
Total Devices Revenue	2,664,834	4,192,754
MRI compatible patient vital signs monitoring systems
Disaggregation of Revenue
Total Devices Revenue	$ 2,888,703	$ 1,766,608

XML 14 R31.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2020

Stock-Based Compensation

Schedule of stock-based compensation


	Three Months Ended
	March 31,
	2020		2019
	(unaudited)
Cost of revenue	$	58,254	$	62,524
General and administrative		362,152		219,705
Sales and marketing		130,955		82,131
Research and development		17,597		17,993
Total	$	568,958	$	382,353

Summary of stock options and restricted stock units activity

The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2020 (shares):


	Stock	Restricted
	Options	Stock Units
Outstanding beginning of period	638,860	297,048
Awards granted	—	18,129
Awards exercised/vested	(190,540)	(19,844)
Awards canceled	(500)	(25,724)
Outstanding end of period	447,820	269,609

XML 15 R39.htm IDEA: XBRL DOCUMENT

Inventory (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Inventory
Raw materials	$ 3,513,972	$ 2,939,451
Work in process	282,198	229,479
Finished goods	647,509	697,483
Inventory before allowance for excess and obsolete	4,443,679	3,866,413
Allowance for excess and obsolete	(228,718)	(224,852)
Total	$ 4,214,961	$ 3,641,561

XML 16 R50.htm IDEA: XBRL DOCUMENT

Leases - Operating Lease Cost (Details) - USD ($)	3 Months Ended
Leases - Operating Lease Cost (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Leases
Operating lease cost	$ 102,398	$ 102,399
Cost of revenue
Leases
Operating lease cost	46,535	46,535
General and administrative
Leases
Operating lease cost	46,044	46,044
Sales and marketing
Leases
Operating lease cost	2,604	2,605
Research and development
Leases
Operating lease cost	$ 7,215	$ 7,215

XML 17 R45.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Income (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Component of accumulated other comprehensive loss
Balance at the beginning	$ 30,374
Gains on available-for-sale securities, net	10,433	$ 35,317
Reclassification realized in net earnings		(2,877)
Balance at the end	$ 40,807	$ (3,998)

XML 18 R41.htm IDEA: XBRL DOCUMENT

Property and Equipment - Geographic information (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Property and equipment
Property and equipment, net	$ 2,099,778	$ 2,053,806
United States
Property and equipment
Property and equipment, net	1,757,458	1,689,740
International
Property and equipment
Property and equipment, net	$ 342,320	$ 364,066

XML 19 R49.htm IDEA: XBRL DOCUMENT

Leases (Details)	1 Months Ended	3 Months Ended
Leases (Details)	Jan. 31, 2014 USD ($)	Mar. 31, 2020
Leases
Lessee, operating lease, existence of residual value guarantee		false
Susi, LLC \| Winter Springs, Florida Facility
Leases
Monthly base rent	$ 34,133
Number of successive renewal terms of lease	1
Renewal term of lease beginning in 2019	5 years
Renewal term of lease beginning in 2024	5 years
Renewal term lease thereafter	1 year
Remaining lease term (in years)		9 years 2 months 12 days

XML 20 R8.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Operating activities:
Net income	$ 1,769,211	$ 1,845,565
Adjustments to reconcile net income to net cash provided by operating activities:
Change in allowance for doubtful accounts	36,756	21,450
Change in provision for excess and obsolete inventory	128,143	120,529
Depreciation and amortization	344,784	387,081
Stock-based compensation	568,958	382,353
Deferred income taxes, net	(32,472)	59,048
Loss on maturities of investments		3,826
Changes in operating assets and liabilities:
Accounts receivable	1,404,704	(1,140,008)
Inventory	(560,996)	(333,546)
Prepaid expenses and other current assets	(538,093)	(665,862)
Other assets	(60,614)	(4,891)
Accounts payable	(266,644)	375,202
Accrued payroll and benefits	(542,834)	(378,354)
Other accrued taxes	(469,750)	(46,832)
Warranty reserve	7,924	(341)
Deferred revenue	308,559	338,078
Prepaid income taxes	(901,001)	(298,094)
Net cash provided by operating activities	1,196,635	665,204
Investing activities:
Proceeds from maturity of investments		650,000
Purchases of property and equipment	(166,593)	(82,943)
Capitalized intangible assets	(63,782)	(9,724)
Net cash (used in) provided by investing activities	(230,375)	557,333
Financing activities:
Proceeds from stock option exercises	322,179	456,739
Taxes paid for the net share settlement of equity awards	(133,872)	(22,507)
Net cash provided by financing activities	188,307	434,232
Net increase in cash and cash equivalents	1,154,567	1,656,769
Cash and cash equivalents, beginning of period	43,481,781	28,027,688
Cash and cash equivalents, end of period	44,636,348	29,684,457
Supplemental disclosure of cash flow information:
Right-of-use asset recognized in exchange for new lease obligation		3,182,724
Operating and short-term lease payments recorded within cash flow from operating activities	$ 107,081	$ 106,659

XML 21 R4.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Mar. 31, 2020	Mar. 31, 2019
STATEMENTS OF OPERATIONS
Revenue	$ 8,677,541	$ 8,437,593
Cost of revenue	2,213,730	2,047,827
Gross profit	6,463,811	6,389,766
Operating expenses:
General and administrative	2,862,727	2,412,696
Sales and marketing	2,433,567	2,110,652
Research and development	430,282	352,573
Total operating expenses	5,726,576	4,875,921
Income from operations	737,235	1,513,845
Other income, net	98,502	92,574
Income before provision for income taxes	835,737	1,606,419
Provision for income tax benefit	(933,474)	(239,146)
Net income	$ 1,769,211	$ 1,845,565
Net income per share:
Basic (in dollars per share)	$ 0.15	$ 0.17
Diluted (in dollars per share)	$ 0.14	$ 0.15
Weighted average shares outstanding:
Basic (in shares)	11,891,428	11,029,639
Diluted (in shares)	12,365,605	12,227,696

XML 22 R28.htm IDEA: XBRL DOCUMENT

Investments (Tables)

3 Months Ended

Mar. 31, 2020

Investments

Summary of available-for-sale securities


		March 31, 2020
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
Corporate bonds:
U.S. corporations	$	2,258,686	$	45,342	$	—	$	2,304,028
International corporations		471,139		6,995		—		478,134
Total	$	2,729,825	$	52,337	$	—	$	2,782,162


		December 31, 2019
			Gross		Gross
			Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
Corporate bonds:
U.S. corporations	$	2,258,686	$	29,123	$	—	$	2,287,809
International corporations		471,139		9,339		—		480,478
Total	$	2,729,825	$	38,462	$	—	$	2,768,287

XML 23 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 102 275 1 false 30 0 false 5 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.iradimed.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONDENSED BALANCE SHEETS Sheet http://www.iradimed.com/role/StatementCondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.iradimed.com/role/StatementCondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONDENSED STATEMENTS OF OPERATIONS Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfOperations CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00300 - Statement - CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfComprehensiveIncome CONDENSED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 00305 - Statement - CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfComprehensiveIncomeParenthetical CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfStockholdersEquity CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 7 false false R8.htm 00500 - Statement - CONDENSED STATEMENTS OF CASH FLOWS Sheet http://www.iradimed.com/role/StatementCondensedStatementsOfCashFlows CONDENSED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 10101 - Disclosure - Basis of Presentation Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 10201 - Disclosure - Revenue Revenue Recognition Sheet http://www.iradimed.com/role/DisclosureRevenueRevenueRecognition Revenue Revenue Recognition Notes 10 false false R11.htm 10301 - Disclosure - Basic and Diluted Net Income per Share Sheet http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShare Basic and Diluted Net Income per Share Notes 11 false false R12.htm 10401 - Disclosure - Inventory Sheet http://www.iradimed.com/role/DisclosureInventory Inventory Notes 12 false false R13.htm 10501 - Disclosure - Property and Equipment Sheet http://www.iradimed.com/role/DisclosurePropertyAndEquipment Property and Equipment Notes 13 false false R14.htm 10601 - Disclosure - Intangible Assets Sheet http://www.iradimed.com/role/DisclosureIntangibleAssets Intangible Assets Notes 14 false false R15.htm 10701 - Disclosure - Investments Sheet http://www.iradimed.com/role/DisclosureInvestments Investments Notes 15 false false R16.htm 10801 - Disclosure - Fair Value Measurements Sheet http://www.iradimed.com/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 10901 - Disclosure - Accumulated Other Comprehensive Income Sheet http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Notes 17 false false R18.htm 11001 - Disclosure - Stock-Based Compensation Sheet http://www.iradimed.com/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 11101 - Disclosure - Income Taxes Sheet http://www.iradimed.com/role/DisclosureIncomeTaxes Income Taxes Notes 19 false false R20.htm 11201 - Disclosure - Leases Sheet http://www.iradimed.com/role/DisclosureLeases Leases Notes 20 false false R21.htm 11301 - Disclosure - Commitments and Contingencies Sheet http://www.iradimed.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 20102 - Disclosure - Basis of Presentation (Policies) Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentationPolicies Basis of Presentation (Policies) Policies 22 false false R23.htm 30203 - Disclosure - Revenue Recognition (Tables) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionTables Revenue Recognition (Tables) Tables 23 false false R24.htm 30303 - Disclosure - Basic and Diluted Net Income per Share (Tables) Sheet http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShareTables Basic and Diluted Net Income per Share (Tables) Tables http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShare 24 false false R25.htm 30403 - Disclosure - Inventory (Tables) Sheet http://www.iradimed.com/role/DisclosureInventoryTables Inventory (Tables) Tables http://www.iradimed.com/role/DisclosureInventory 25 false false R26.htm 30503 - Disclosure - Property and Equipment (Tables) Sheet http://www.iradimed.com/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://www.iradimed.com/role/DisclosurePropertyAndEquipment 26 false false R27.htm 30603 - Disclosure - Intangible Assets (Tables) Sheet http://www.iradimed.com/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) Tables http://www.iradimed.com/role/DisclosureIntangibleAssets 27 false false R28.htm 30703 - Disclosure - Investments (Tables) Sheet http://www.iradimed.com/role/DisclosureInvestmentsTables Investments (Tables) Tables http://www.iradimed.com/role/DisclosureInvestments 28 false false R29.htm 30803 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.iradimed.com/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.iradimed.com/role/DisclosureFairValueMeasurements 29 false false R30.htm 30903 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Tables http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveIncome 30 false false R31.htm 31003 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.iradimed.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.iradimed.com/role/DisclosureStockBasedCompensation 31 false false R32.htm 31203 - Disclosure - Leases (Tables) Sheet http://www.iradimed.com/role/DisclosureLeasesTables Leases (Tables) Tables http://www.iradimed.com/role/DisclosureLeases 32 false false R33.htm 40101 - Disclosure - Basis of Presentation (Details) Sheet http://www.iradimed.com/role/DisclosureBasisOfPresentationDetails Basis of Presentation (Details) Details http://www.iradimed.com/role/DisclosureBasisOfPresentationPolicies 33 false false R34.htm 40201 - Disclosure - Revenue Recognition - Information by geographic region (Details) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionInformationByGeographicRegionDetails Revenue Recognition - Information by geographic region (Details) Details 34 false false R35.htm 40202 - Disclosure - Revenue Recognition - Information by Type (Details) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionInformationByTypeDetails Revenue Recognition - Information by Type (Details) Details 35 false false R36.htm 40203 - Disclosure - Revenue Recognition - Contract Liabilities (Details) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionContractLiabilitiesDetails Revenue Recognition - Contract Liabilities (Details) Details 36 false false R37.htm 40204 - Disclosure - Revenue Recognition - Capitalized Contract Costs (Details) Sheet http://www.iradimed.com/role/DisclosureRevenueRecognitionCapitalizedContractCostsDetails Revenue Recognition - Capitalized Contract Costs (Details) Details 37 false false R38.htm 40301 - Disclosure - Basic and Diluted Net Income per Share (Details) Sheet http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShareDetails Basic and Diluted Net Income per Share (Details) Details http://www.iradimed.com/role/DisclosureBasicAndDilutedNetIncomePerShareTables 38 false false R39.htm 40401 - Disclosure - Inventory (Details) Sheet http://www.iradimed.com/role/DisclosureInventoryDetails Inventory (Details) Details http://www.iradimed.com/role/DisclosureInventoryTables 39 false false R40.htm 40501 - Disclosure - Property and Equipment (Details) Sheet http://www.iradimed.com/role/DisclosurePropertyAndEquipmentDetails Property and Equipment (Details) Details http://www.iradimed.com/role/DisclosurePropertyAndEquipmentTables 40 false false R41.htm 40502 - Disclosure - Property and Equipment - Geographic information (Details) Sheet http://www.iradimed.com/role/DisclosurePropertyAndEquipmentGeographicInformationDetails Property and Equipment - Geographic information (Details) Details 41 false false R42.htm 40601 - Disclosure - Intangible Assets (Details) Sheet http://www.iradimed.com/role/DisclosureIntangibleAssetsDetails Intangible Assets (Details) Details http://www.iradimed.com/role/DisclosureIntangibleAssetsTables 42 false false R43.htm 40701 - Disclosure - Investments (Details) Sheet http://www.iradimed.com/role/DisclosureInvestmentsDetails Investments (Details) Details http://www.iradimed.com/role/DisclosureInvestmentsTables 43 false false R44.htm 40801 - Disclosure - Fair Value Measurements (Details) Sheet http://www.iradimed.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.iradimed.com/role/DisclosureFairValueMeasurementsTables 44 false false R45.htm 40901 - Disclosure - Accumulated Other Comprehensive Income (Details) Sheet http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Details) Details http://www.iradimed.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables 45 false false R46.htm 41001 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.iradimed.com/role/DisclosureStockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.iradimed.com/role/DisclosureStockBasedCompensationTables 46 false false R47.htm 41002 - Disclosure - Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details) Sheet http://www.iradimed.com/role/DisclosureStockBasedCompensationStockOptionsAndRestrictedStockUnitsActivityDetails Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details) Details 47 false false R48.htm 41101 - Disclosure - Income Taxes (Details) Sheet http://www.iradimed.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.iradimed.com/role/DisclosureIncomeTaxes 48 false false R49.htm 41201 - Disclosure - Leases (Details) Sheet http://www.iradimed.com/role/DisclosureLeasesDetails Leases (Details) Details http://www.iradimed.com/role/DisclosureLeasesTables 49 false false R50.htm 41202 - Disclosure - Leases - Operating Lease Cost (Details) Sheet http://www.iradimed.com/role/DisclosureLeasesOperatingLeaseCostDetails Leases - Operating Lease Cost (Details) Details 50 false false R51.htm 41203 - Disclosure - Leases - Maturity of Lease Liabilities (Details) Sheet http://www.iradimed.com/role/DisclosureLeasesMaturityOfLeaseLiabilitiesDetails Leases - Maturity of Lease Liabilities (Details) Details 51 false false R52.htm 41301 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.iradimed.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.iradimed.com/role/DisclosureCommitmentsAndContingencies 52 false false All Reports Book All Reports irmd-20200331.xml irmd-20200331.xsd irmd-20200331_cal.xml irmd-20200331_def.xml irmd-20200331_lab.xml irmd-20200331_pre.xml http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 true true XML 24 R20.htm IDEA: XBRL DOCUMENT

Leases

3 Months Ended

Mar. 31, 2020

Leases

Leases

12 — Leases

Operating lease cost recognized in the Condensed Statements of Operations is as follows:


	Three Months Ended
	March 31,
	2020		2019
Cost of revenue	$	46,535	$	46,535
General and administrative		46,044		46,044
Sales and marketing		2,604		2,605
Research and development		7,215		7,215
Total	$	102,398	$	102,399

Lease costs for short-term leases were immaterial for the three months ended March 31, 2020.

Maturity of Operating Lease Liability as of March 31, 2020 is as follows:


Nine months ending December 31, 2020	$	307,197
2021		409,596
2022		409,596
2023		409,596
2024		409,596
Thereafter		1,809,050
Total lease payments		3,754,631
Imputed interest		(857,624)
Present value of lease liability	$	2,897,007

XML 25 R24.htm IDEA: XBRL DOCUMENT

Basic and Diluted Net Income per Share (Tables)

3 Months Ended

Mar. 31, 2020

Basic and Diluted Net Income per Share

Schedule of computation of basic and diluted net income per share


	Three Months Ended March 31,
	2020		2019
	(unaudited)
Net income	$	1,769,211	$	1,845,565
Weighted-average shares outstanding — Basic		11,891,428		11,029,639
Effect of dilutive securities:
Underwriters’ warrants		—		99,814
Stock options		414,439		996,303
Restricted stock units		59,738		101,940
Weighted-average shares outstanding — Diluted		12,365,605		12,227,696
Basic net income per share	$	0.15	$	0.17
Diluted net income per share	$	0.14	$	0.15

Schedule of stock options and restricted stock units excluded from the calculation of diluted net income per share


	Three Months Ended
	March 31,
	2020	2019
	(unaudited)
Anti-dilutive stock options and restricted stock units	62,904	7,123

XML 26 R48.htm IDEA: XBRL DOCUMENT

Income Taxes (Details) - USD ($)	3 Months Ended
Income Taxes (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Reconciliation of the statutory U.S. federal tax rate to effective rate
Provision for income tax benefit	$ (933,474)	$ (239,146)
Effective tax rate (as a percent)	(111.70%)	(14.90%)

XML 27 R44.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Fair Value Measurements
Fair value assets, amount transferred between measurement levels	$ 0	$ 0
Fair value liabilities, amount transferred between measurement levels	0	0
Recurring
Fair Value Measurements
Total	2,782,162	2,768,287
Recurring \| U.S. corporations
Fair Value Measurements
Total	2,304,028	2,287,809
Recurring \| International corporations
Fair Value Measurements
Total	478,134	480,478
Recurring \| Significant Other Observable Inputs (Level 2)
Fair Value Measurements
Total	2,782,162	2,768,287
Recurring \| Significant Other Observable Inputs (Level 2) \| U.S. corporations
Fair Value Measurements
Total	2,304,028	2,287,809
Recurring \| Significant Other Observable Inputs (Level 2) \| International corporations
Fair Value Measurements
Total	$ 478,134	$ 480,478

XML 28 R40.htm IDEA: XBRL DOCUMENT

Property and Equipment (Details) - USD ($)	3 Months Ended
Property and Equipment (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Property and equipment
Property and equipment, gross	$ 4,079,558		$ 3,907,644
Accumulated depreciation	(1,979,780)		(1,853,838)
Total	2,099,778		2,053,806
Depreciation expense of property and equipment	126,308	$ 124,341
Computer software and hardware
Property and equipment
Property and equipment, gross	647,988		627,624
Furniture and fixtures
Property and equipment
Property and equipment, gross	1,117,693		1,112,550
Leasehold improvements
Property and equipment
Property and equipment, gross	225,841		225,841
Machinery and equipment
Property and equipment
Property and equipment, gross	1,796,394		1,778,524
Tooling in-process
Property and equipment
Property and equipment, gross	$ 291,642		$ 163,105

XML 29 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2020	May 01, 2020
Document and Entity Information
Entity Registrant Name	IRADIMED CORPORATION
Entity Central Index Key	0001325618
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		12,049,978
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1

XML 30 R5.htm IDEA: XBRL DOCUMENT

CONDENSED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	Mar. 31, 2020	Mar. 31, 2019
STATEMENTS OF COMPREHENSIVE INCOME
Net income	$ 1,769,211	$ 1,845,565
Other comprehensive income:
Change in fair value of available-for-sale securities, net of tax expense of $3,442 and $11,656, respectively	10,433	35,317
Realized loss on available-for-sale securities reclassified to net income, net of tax benefit of $0 and $949, respectively		2,877
Other comprehensive income	10,433	38,194
Comprehensive income	$ 1,779,644	$ 1,883,759

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 31 R9.htm IDEA: XBRL DOCUMENT

Basis of Presentation	3 Months Ended
Basis of Presentation	Mar. 31, 2020
Basis of Presentation
Basis of Presentation	IRADIMED CORPORATION Notes to Unaudited Condensed Financial Statements 1 — Basis of Presentation The accompanying interim condensed financial statements of IRADIMED CORPORATION (“IRADIMED”, the “Company”, “we”, “our”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally presented in annual financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to such rules and regulations. The interim financial information is unaudited, but reflects all normal adjustments that are, in the opinion of management, necessary for the fair presentation of our financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. These accompanying interim condensed financial statements should be read with the financial statements and related footnotes to financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019. The accounting policies followed in the preparation of these interim condensed financial statements, except as described in Note 1, are consistent in all material respects with those described in Note 1 of our Form 10-K. We operate in one reportable segment which is the development, manufacture and sale of MRI compatible medical devices, related accessories, disposables and services for use by hospitals and acute care facilities during MRI procedures. Certain Significant Risks and Uncertainties We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. COVID-19 Considerations We are subject to risks and uncertainties as a result of the spread of COVID-19. The extent of the impact of COVID-19 on our business is highly uncertain and difficult to predict. Our future results of operations and liquidity could be adversely impacted by delays in payments, supply chain disruptions, and uncertain demand. As of the date of the issuance of these financial statements, the extent to which COVID-19 may materially impact our financial condition, liquidity, or results of operations in future periods is uncertain. Recent Accounting Pronouncements Recently Issued Accounting Pronouncements to be Implemented In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 will be effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We do not expect ASU 2019-12 to have a material impact on financial condition, results of operations or cash flows. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. In November 2018, April 2019 and May 2019, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses and ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, which provided additional implementation guidance on ASU 2016-03. The previously mentioned ASUs are effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We do not expect the adoption of these ASUs to have a material impact on our financial condition, results of operations or cash flows.

XML 32 R21.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2020
Commitments and Contingencies
Commitments and Contingencies	13 — Commitments and Contingencies Purchase commitments. We had various purchase orders for goods or services totaling $3,631,996 and $3,208,174 as of March 31, 2020 and December 31, 2019, respectively. No amounts related to these purchase orders have been recognized in our balance sheet. Legal matters. We may from time to time become party to various legal proceedings or claims that arise in the ordinary course of business.

XML 33 R25.htm IDEA: XBRL DOCUMENT

Inventory (Tables)

3 Months Ended

Mar. 31, 2020

Inventory

Schedule of inventory


	March 31,		December 31,
	2020		2019
	(unaudited)
Raw materials	$	3,513,972	$	2,939,451
Work in process		282,198		229,479
Finished goods		647,509		697,483
Inventory before allowance for excess and obsolete		4,443,679		3,866,413
Allowance for excess and obsolete		(228,718)		(224,852)
Total	$	4,214,961	$	3,641,561

XML 34 R29.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2020

Fair Value Measurements

Schedule of the fair value of assets and liabilities subject to recurring fair value measurements


	Fair Value at March 31, 2020
			Quoted Prices		Significant
			in Active		Other		Significant
			Market for		Observable		Unobservable
	Fair		Identical Assets		Inputs		Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
Corporate bonds:
U.S. corporations	$	2,304,028	$	—	$	2,304,028	$	—
International corporations		478,134		—		478,134		—
Total	$	2,782,162	$	—	$	2,782,162	$	—


	Fair Value at December 31, 2019
			Quoted Prices		Significant
			in Active		Other		Significant
			Market for		Observable		Unobservable
	Fair		Identical Assets		Inputs		Inputs
	Value		(Level 1)		(Level 2)		(Level 3)
Corporate bonds:
U.S. corporations	$	2,287,809	$	—	$	2,287,809	$	—
International corporations		480,478		—		480,478		—
Total	$	2,768,287	$	—	$	2,768,287	$	—

XML 35 R13.htm IDEA: XBRL DOCUMENT

Property and Equipment

3 Months Ended

Mar. 31, 2020

Property and Equipment

Property and Equipment

5 — Property and Equipment

Property and equipment consist of:


	March 31,		December 31,
	2020		2019
	(unaudited)
Computer software and hardware	$	647,988	$	627,624
Furniture and fixtures		1,117,693		1,112,550
Leasehold improvements		225,841		225,841
Machinery and equipment		1,796,394		1,778,524
Tooling in-process		291,642		163,105
		4,079,558		3,907,644
Accumulated depreciation		(1,979,780)		(1,853,838)
Total	$	2,099,778	$	2,053,806

Depreciation expense of property and equipment was $126,308 and $124,341 for the three months ended March 31, 2020 and 2019, respectively.

Property and equipment, net, information by geographic region is as follows:


	March 31,		December 31,
	2020		2019
	(unaudited)
United States	$	1,757,458	$	1,689,740
International		342,320		364,066
Total property and equipment, net	$	2,099,778	$	2,053,806

Long-lived assets held outside of the United States consist principally of tooling and machinery and equipment, which are components of property and equipment, net.

XML 36 R17.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Income

3 Months Ended

Mar. 31, 2020

Accumulated Other Comprehensive Income (Loss)

Accumulated Other Comprehensive Income (Loss)

9 — Accumulated Other Comprehensive Income

The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2020 and 2019 are as follows:


	Unrealized (Losses)
	Gains on
	Available-For-Sale
	Securities
Balance at December 31, 2019	$	30,374
Gains on available-for-sale securities, net		10,433
Reclassification realized in net earnings		—
Balance at March 31, 2020	$	40,807

Balance at December 31, 2018	$	(42,192)
Gains on available-for-sale securities, net		35,317
Reclassification realized in net earnings		2,877
Balance at March 31, 2019	$	(3,998)

XML 37 R38.htm IDEA: XBRL DOCUMENT

Basic and Diluted Net Income per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Basic and Diluted Net Income per Share
Net income	$ 1,769,211	$ 1,845,565
Weighted-average shares outstanding - Basic (in shares)	11,891,428	11,029,639
Effect of dilutive securities:
Underwriters' warrants		99,814
Stock options	414,439	996,303
Restricted stock units	59,738	101,940
Weighted-average shares outstanding - Diluted (in shares)	12,365,605	12,227,696
Basic net income per share (in dollars per share)	$ 0.15	$ 0.17
Diluted net income per share (in dollars per share)	$ 0.14	$ 0.15
Anti-dilutive stock
Anti-dilutive stock options and restricted stock units	62,904	7,123

XML 38 R34.htm IDEA: XBRL DOCUMENT

Revenue Recognition - Information by geographic region (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Contract Liabilities
Total revenue	$ 8,677,541	$ 8,437,593
United States
Contract Liabilities
Total revenue	6,322,106	7,073,735
International
Contract Liabilities
Total revenue	$ 2,355,435	$ 1,363,858

XML 39 R30.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Income (Tables)

3 Months Ended

Mar. 31, 2020

Accumulated Other Comprehensive Income (Loss)

Schedule of components of accumulated other comprehensive loss, net of tax

The components of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2020 and 2019 are as follows:


	Unrealized (Losses)
	Gains on
	Available-For-Sale
	Securities
Balance at December 31, 2019	$	30,374
Gains on available-for-sale securities, net		10,433
Reclassification realized in net earnings		—
Balance at March 31, 2020	$	40,807

Balance at December 31, 2018	$	(42,192)
Gains on available-for-sale securities, net		35,317
Reclassification realized in net earnings		2,877
Balance at March 31, 2019	$	(3,998)

XML 40 R51.htm IDEA: XBRL DOCUMENT

Leases - Maturity of Lease Liabilities (Details)	Mar. 31, 2020 USD ($)
Operating leases
Nine months ending December 31, 2020	$ 307,197
2021	409,596
2022	409,596
2023	409,596
2024	409,596
Thereafter	1,809,050
Total lease payments	3,754,631
Imputed interest	(857,624)
Present value of lease liability	$ 2,897,007

ZIP 41 0001104659-20-057715-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-057715-xbrl.zip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ϟ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end XML 42 R3.htm IDEA: XBRL DOCUMENT v3.20.1

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)

Mar. 31, 2020

Dec. 31, 2019

CONDENSED BALANCE SHEETS

Accounts receivable, allowance for doubtful accounts $ 104,547 $ 69,093

Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001

Common stock, shares authorized 31,500,000 31,500,000

Common stock, shares issued 11,970,937 11,765,875

Common stock, shares outstanding 11,970,937 11,765,875

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R7.htm IDEA: XBRL DOCUMENT v3.20.1

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)

Common Stock

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Total

Balances at Dec. 31, 2018 $ 1,099 $ 15,317,335 $ 26,669,491 $ (42,192)

Increase (Decrease) in Stockholders' Equity

Net income 1,845,565 $ 1,845,565

Other comprehensive income 38,194

Stock-based compensation 382,353

Net share settlement of restricted stock units (22,507)

Exercise of stock options and warrants 15 456,724

Balances at Mar. 31, 2019 1,114 16,133,905 28,515,056 (3,998) 44,646,077

Balances at Dec. 31, 2019 1,177 19,192,394 36,300,450 30,374 55,524,395

Increase (Decrease) in Stockholders' Equity

Net income 1,769,211 1,769,211

Other comprehensive income 10,433

Stock-based compensation 568,958

Net share settlement of restricted stock units 1 (133,873)

Exercise of stock options and warrants 19 322,160

Balances at Mar. 31, 2020 $ 1,197 $ 19,949,639 $ 38,069,661 $ 40,807 $ 58,061,304

X

- Definition
Value of stock issued as a result of the exercise of stock options and warrants.
+ References
No definition available.
+ Details

Name: irmd_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised

Namespace Prefix: irmd_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=109196918&loc=d3e11149-113907

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109196918&loc=d3e11178-113907

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=79507207&loc=d3e4534-113899
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The value of restricted shares issued as compensation, net of the value of shares for the payment of withholding taxes. This element is to be used only if shares are used in lieu of cash to satisfy all or a portion of withholding taxes.
+ References
No definition available.
+ Details

Name: us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 44 R46.htm IDEA: XBRL DOCUMENT v3.20.1

Stock-Based Compensation (Details) - USD ($)
3 Months Ended

Mar. 31, 2020

Mar. 31, 2019

Stock-Based Compensation

Total stock-based compensation expense $ 568,958 $ 382,353

Cost of revenue

Stock-Based Compensation

Total stock-based compensation expense 58,254 62,524

General and administrative

Stock-Based Compensation

Total stock-based compensation expense 362,152 219,705

Sales and marketing

Stock-Based Compensation

Total stock-based compensation expense 130,955 82,131

Research and development

Stock-Based Compensation

Total stock-based compensation expense $ 17,597 $ 17,993

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 45 R42.htm IDEA: XBRL DOCUMENT v3.20.1

Intangible Assets (Details) - USD ($)
3 Months Ended

Mar. 31, 2020

Mar. 31, 2019

Dec. 31, 2019

Intangible assets

Intangible Assets, gross $ 1,463,056 $ 1,399,274

Accumulated amortization (561,678) (539,187)

Total 901,378 860,087

Amortization expense of intangible assets 22,491 $ 22,491

Expected annual amortization expense

Nine months ending December 31, 2020 67,472

2021 89,963

2022 89,392

2023 88,740

2024 88,439

2025 87,446

Patents - in use

Intangible assets

Intangible Assets, gross 304,270 304,270

Patents - in process

Intangible assets

Intangible Assets, gross 139,641 120,581

Internally developed software - in use

Intangible assets

Intangible Assets, gross 867,569 867,569

Internally developed software - in process

Intangible assets

Intangible Assets, gross 124,808 80,721

Trademarks

Intangible assets

Intangible Assets, gross $ 26,768 $ 26,133

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the sixth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
No definition available.
+ Details

Name: irmd_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix

Namespace Prefix: irmd_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 928
-SubTopic 340
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=irmd_PatentsInUseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=irmd_PatentsInProcessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=irmd_SoftwareDevelopmentInUseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=irmd_SoftwareDevelopmentInProcessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 R23.htm IDEA: XBRL DOCUMENT v3.20.1

Revenue Recognition (Tables)
3 Months Ended

Mar. 31, 2020

Revenue Recognition

Schedule of disaggregation of revenue by geographic region and revenue type

Revenue information by geographic region is as follows:

Three Months Ended

March 31,



2020



2019

(unaudited)

United States

$

6,322,106

$

7,073,735

International

2,355,435

1,363,858

Total revenue

$

8,677,541

$

8,437,593

Revenue information by type is as follows:

Three Months Ended

March 31,



2020



2019

(unaudited)

Devices:





MRI compatible IV infusion pump system

$

2,664,834

$

4,192,754

MRI compatible patient vital signs monitoring systems

2,888,703

1,766,608

Total Devices revenue

5,553,537

5,959,362

Disposables, services and other

2,662,713

2,036,674

Amortization of extended warranty agreements

461,291

441,557

Total revenue

$

8,677,541

$

8,437,593

Schedule of contract liabilities and changes in the contract liabilities

Our contract liabilities consist of:



March 31,



December 31,

2020

2019

(unaudited)

Advance payments from customers

$

35,306

$

12,765

Shipments in-transit

22,345

4,250

Extended warranty agreements

4,530,360

4,284,872

Total

$

4,588,011

$

4,301,887

Changes in the contract liabilities during the periods presented are as follows:



Deferred

Revenue

Contract liabilities, December 31, 2019

$

4,301,887

Increases due to cash received from customers

779,048

Decreases due to recognition of revenue

(492,924)

Contract liabilities, March 31, 2020

$

4,588,011



Deferred

Revenue

Contract liabilities, December 31, 2018

$

3,605,789

Increases due to cash received from customers

813,298

Decreases due to recognition of revenue

(652,564)

Contract liabilities, March 31, 2019

$

3,766,523

Schedule of capitalized contract costs

March 31,

December 31,



2020



2019

(unaudited)

Capitalized contract costs

$

412,863

$

352,250

X

- Definition
Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 40
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054
+ Details

Name: us-gaap_CapitalizedContractCostTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of contract balances and changes in contract balances.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045
+ Details

Name: us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045
+ Details

Name: us-gaap_DisaggregationOfRevenueTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenueFromContractWithCustomerAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R27.htm IDEA: XBRL DOCUMENT v3.20.1

Intangible Assets (Tables)
3 Months Ended

Mar. 31, 2020

Intangible Assets

Summary of the components of intangible asset balances



March 31,



December 31,

2020

2019

(unaudited)

Patents — in use

$

304,270

$

304,270

Patents — in process

139,641

120,581

Internally developed software — in use

867,569

867,569

Internally developed software — in process

124,808

80,721

Trademarks

26,768

26,133

1,463,056

1,399,274

Accumulated amortization

(561,678)

(539,187)

Total

$

901,378

$

860,087

Schedule of expected annual amortization expense related to intangible assets (excludes in process intangible assets)

Nine months ending December 31, 2020



$

67,472

2021

89,963

2022

89,392

2023

88,740

2024

88,439

2025

87,446

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R36.htm IDEA: XBRL DOCUMENT v3.20.1

Revenue Recognition - Contract Liabilities (Details) - USD ($)
3 Months Ended

Mar. 31, 2020

Mar. 31, 2019

Mar. 31, 2020

Dec. 31, 2019

Deferred revenue

Advance payments from customers $ 35,306 $ 12,765

Shipments in-transit 22,345 4,250

Extended warranty agreements 4,530,360 4,284,872

Total $ 4,588,011 $ 3,766,523 $ 4,588,011 $ 4,301,887

Changes in contract liabilities

Contract liabilities at beginning of the year 4,301,887 3,605,789

Increases due to cash received from customers 779,048 813,298

Decreases due to recognition of revenue (492,924) (652,564)

Contract liabilities at end of the year $ 4,588,011 $ 3,766,523

X

- Definition
Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.
+ References
No definition available.
+ Details

Name: irmd_AdvancePaymentsFromCustomers

Namespace Prefix: irmd_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of decrease in contract liabilities due to recognition of revenue.
+ References
No definition available.
+ Details

Name: irmd_ContractWithCustomerLiabilityDecreaseDueToRecognitionOfRevenue

Namespace Prefix: irmd_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in contract liabilities due to cash received from customers.
+ References
No definition available.
+ Details

Name: irmd_ContractWithCustomerLiabilityIncreaseDueToCashReceivedFromCustomers

Namespace Prefix: irmd_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized that was previously included in balance of obligation to shipments in-transit.
+ References
No definition available.
+ Details

Name: irmd_ShipmentsInTransit

Namespace Prefix: irmd_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ChangeInContractWithCustomerLiabilityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ContractWithCustomerAssetAndLiabilityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount as of the balance sheet date of the aggregate extended product warranty liability. Does not include the ending balance for the standard product warranty liability.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (c)(1),(c)(5)
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249
+ Details

Name: us-gaap_ExtendedProductWarrantyAccrual

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 50 R32.htm IDEA: XBRL DOCUMENT v3.20.1

Leases (Tables)
3 Months Ended

Mar. 31, 2020

Leases

Schedule of lease cost

Three Months Ended

March 31,



2020



2019

Cost of revenue

$

46,535

$

46,535

General and administrative

46,044

46,044

Sales and marketing

2,604

2,605

Research and development

7,215

7,215

Total

$

102,398

$

102,399

Schedule of maturity of lease liabilities

Nine months ending December 31, 2020



$

307,197

2021

409,596

2022

409,596

2023

409,596

2024

409,596

Thereafter

1,809,050

Total lease payments

3,754,631

Imputed interest

(857,624)

Present value of lease liability

$

2,897,007

X

- Definition
Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_LeaseCostTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_LeasesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R19.htm IDEA: XBRL DOCUMENT v3.20.1

Income Taxes
3 Months Ended

Mar. 31, 2020

Income Taxes

Income Taxes

11 — Income Taxes

For the three months ended March 31, 2020, we recorded a provision for income tax benefit of $(933,474). Our effective tax rate was (111.7) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation and a U.S. state tax benefit. Additionally, we recognized a benefit in our effective tax rate resulting from the Coronavirus Aid, Relief, and Economic Security Act, which allowed us to carryback the net operating loss to years prior to the enactment of the Tax Cuts and Jobs Act.

For the three months ended March 31, 2019, we recorded a provision for income tax benefit of $(239,146). Our effective tax rate was (14.9) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation, partially offset by U.S. state tax expense.

As of March 31, 2020 and December 31, 2019, we had not identified or accrued for any uncertain tax positions. We are currently unaware of any uncertain tax positions that could result in significant payments, accruals or other material deviations in this estimate over the next 12 months. We believe that our tax positions comply in all material respects with applicable tax law. However, tax law is subject to interpretation, and interpretations by taxing authorities could be different from ours, which could result in the imposition of additional taxes and penalties.

We file tax returns in the United States Federal jurisdiction and many U.S. state jurisdictions. The Company is subject to income tax examinations for our United States Federal and certain U.S. state income taxes for 2016 and subsequent years and various other U.S. state income taxes for 2015 and subsequent years.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R11.htm IDEA: XBRL DOCUMENT v3.20.1

Basic and Diluted Net Income per Share
3 Months Ended

Mar. 31, 2020

Basic and Diluted Net Income per Share

Basic and Diluted Net Income per Share

3 — Basic and Diluted Net Income per Share

Basic net income per share is based upon the weighted-average number of common shares outstanding during the period. Diluted net income per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. Stock options and restricted stock units granted by us represent the only dilutive effect reflected in diluted weighted-average shares outstanding.

The following table presents the computation of basic and diluted net income per share:

Three Months Ended March 31,



2020



2019

(unaudited)

Net income

$

1,769,211

$

1,845,565

Weighted-average shares outstanding — Basic

11,891,428

11,029,639

Effect of dilutive securities:

Underwriters’ warrants

—

99,814

Stock options

414,439

996,303

Restricted stock units

59,738

101,940

Weighted-average shares outstanding — Diluted

12,365,605

12,227,696

Basic net income per share

$

0.15

$

0.17

Diluted net income per share

$

0.14

$

0.15

Stock options and restricted stock units excluded from the calculation of diluted net income per share because the effect would have been anti-dilutive are as follows:

Three Months Ended

March 31,



2020



2019

(unaudited)

Anti-dilutive stock options and restricted stock units

62,904

7,123

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-URI http://asc.fasb.org/topic&trid=2144383
+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 R15.htm IDEA: XBRL DOCUMENT v3.20.1

Investments
3 Months Ended

Mar. 31, 2020

Investments

Investments

7 — Investments

Our investments consist of corporate bonds that we have classified as available-for-sale and are summarized in the following tables:

March 31, 2020

Gross

Gross

Unrealized

Unrealized

Fair



Cost



Gains



Losses



Value

Corporate bonds:

U.S. corporations

$

2,258,686

$

45,342

$

—

$

2,304,028

International corporations

471,139

6,995

—

478,134

Total

$

2,729,825

$

52,337

$

—

$

2,782,162

December 31, 2019

Gross

Gross

Unrealized

Unrealized

Fair



Cost



Gains



Losses



Value

Corporate bonds:

U.S. corporations

$

2,258,686

$

29,123

$

—

$

2,287,809

International corporations

471,139

9,339

—

480,478

Total

$

2,729,825

$

38,462

$

—

$

2,768,287

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for investments in certain debt and equity securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2209399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2324412

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-URI http://asc.fasb.org/topic&trid=2196928

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2176304
+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 55 R37.htm IDEA: XBRL DOCUMENT v3.20.1

Revenue Recognition - Capitalized Contract Costs (Details) - USD ($)
3 Months Ended 12 Months Ended

Mar. 31, 2020

Dec. 31, 2019

Revenue Recognition

Capitalized contract costs $ 412,863 $ 352,250

Expense related to amortization of capitalized contract costs $ 28,169 $ 22,713

X

- Definition
Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 40
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054
+ Details

Name: us-gaap_CapitalizedContractCostAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 40
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054
+ Details

Name: us-gaap_CapitalizedContractCostNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_RevenueFromContractWithCustomerAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 56 R33.htm IDEA: XBRL DOCUMENT v3.20.1

Basis of Presentation (Details)
3 Months Ended

Mar. 31, 2020

segment

Basis of Presentation

Number of reportable segment 1

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 57 R10.htm IDEA: XBRL DOCUMENT v3.20.1

Revenue Revenue Recognition
3 Months Ended

Mar. 31, 2020

Revenue Recognition

Revenue Recognition

2 — Revenue Recognition

Disaggregation of Revenue

We disaggregate revenue from contracts with customers by geographic region and revenue type as we believe it best depicts the nature, amount, timing and uncertainty of our revenue and cash flow.

Revenue information by geographic region is as follows:

Three Months Ended

March 31,



2020



2019

(unaudited)

United States

$

6,322,106

$

7,073,735

International

2,355,435

1,363,858

Total revenue

$

8,677,541

$

8,437,593

Revenue information by type is as follows:

Three Months Ended

March 31,



2020



2019

(unaudited)

Devices:





MRI compatible IV infusion pump system

$

2,664,834

$

4,192,754

MRI compatible patient vital signs monitoring systems

2,888,703

1,766,608

Total Devices revenue

5,553,537

5,959,362

Disposables, services and other

2,662,713

2,036,674

Amortization of extended warranty agreements

461,291

441,557

Total revenue

$

8,677,541

$

8,437,593

Contract Liabilities

Our contract liabilities consist of:



March 31,



December 31,

2020

2019

(unaudited)

Advance payments from customers

$

35,306

$

12,765

Shipments in-transit

22,345

4,250

Extended warranty agreements

4,530,360

4,284,872

Total

$

4,588,011

$

4,301,887

Changes in the contract liabilities during the periods presented are as follows:



Deferred

Revenue

Contract liabilities, December 31, 2019

$

4,301,887

Increases due to cash received from customers

779,048

Decreases due to recognition of revenue

(492,924)

Contract liabilities, March 31, 2020

$

4,588,011



Deferred

Revenue

Contract liabilities, December 31, 2018

$

3,605,789

Increases due to cash received from customers

813,298

Decreases due to recognition of revenue

(652,564)

Contract liabilities, March 31, 2019

$

3,766,523

Capitalized Contract Costs

Our capitalized contract costs consist of:

March 31,

December 31,



2020



2019

(unaudited)

Capitalized contract costs

$

412,863

$

352,250

Expense related to the amortization of capitalized contract costs was $28,169 and $22,713 for the three months ended March 31, 2020 and 2019, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_RevenueFromContractWithCustomerAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_RevenueFromContractWithCustomerTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 58 R14.htm IDEA: XBRL DOCUMENT v3.20.1

Intangible Assets
3 Months Ended

Mar. 31, 2020

Intangible Assets

Intangible Assets

6 — Intangible Assets

The following table summarizes the components of intangible asset balances:



March 31,



December 31,

2020

2019

(unaudited)

Patents — in use

$

304,270

$

304,270

Patents — in process

139,641

120,581

Internally developed software — in use

867,569

867,569

Internally developed software — in process

124,808

80,721

Trademarks

26,768

26,133

1,463,056

1,399,274

Accumulated amortization

(561,678)

(539,187)

Total

$

901,378

$

860,087

Amortization expense of intangible assets was $22,491 for the three months ended March 31, 2020 and 2019.

Expected annual amortization expense for the remaining portion of 2020 and the next five years related to intangible assets is as follows (excludes in process intangible assets):

Nine months ending December 31, 2020



$

67,472

2021

89,963

2022

89,392

2023

88,740

2024

88,439

2025

87,446

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all or part of the information related to intangible assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-URI http://asc.fasb.org/topic&trid=2144416
+ Details

Name: us-gaap_IntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 59 R18.htm IDEA: XBRL DOCUMENT v3.20.1

Stock-Based Compensation
3 Months Ended

Mar. 31, 2020

Stock-Based Compensation

Stock-Based Compensation

10 — Stock-Based Compensation

Stock-based compensation was recognized as follows in the Condensed Statements of Operations:

Three Months Ended

March 31,



2020



2019

(unaudited)

Cost of revenue

$

58,254

$

62,524

General and administrative

362,152

219,705

Sales and marketing

130,955

82,131

Research and development

17,597

17,993

Total

$

568,958

$

382,353

As of March 31, 2020, we had $500,552 of unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted-average period of 3.4 years. As of March 31, 2020, we had $4,805,263 of unrecognized compensation cost related to unvested restricted stock units, which is expected to be recognized over a weighted-average period of 3.1 years.

The following table presents a summary of our stock-based compensation activity for the three months ended March 31, 2020 (shares):

Stock

Restricted



Options



Stock Units

Outstanding beginning of period

638,860

297,048

Awards granted

—

18,129

Awards exercised/vested

(190,540)

(19,844)

Awards canceled

(500)

(25,724)

Outstanding end of period

447,820

269,609

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-URI http://asc.fasb.org/subtopic&trid=2208855
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 61 R52.htm IDEA: XBRL DOCUMENT v3.20.1

Commitments and Contingencies (Details) - USD ($)

Mar. 31, 2020

Dec. 31, 2019

Purchase commitments

Purchase commitments $ 3,631,996 $ 3,208,174

X

- References
No definition available.
+ Details

Name: irmd_PurchaseCommitmentAbstract

Namespace Prefix: irmd_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.
+ References
No definition available.
+ Details

Name: us-gaap_PurchaseObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 62 R2.htm IDEA: XBRL DOCUMENT v3.20.1

CONDENSED BALANCE SHEETS - USD ($)

Mar. 31, 2020

Dec. 31, 2019

Current assets:

Cash and cash equivalents $ 44,636,348 $ 43,481,781

Accounts receivable, net of allowance for doubtful accounts of $104,547 as of March 31, 2020 and $69,093 as of December 31, 2019 5,851,843 7,293,303

Investments 2,782,162 2,768,287

Inventory, net 4,214,961 3,641,561

Prepaid expenses and other current assets 753,334 407,802

Prepaid income taxes 2,271,948 1,370,947

Total current assets 60,510,596 58,963,681

Property and equipment, net 2,099,778 2,053,806

Intangible assets, net 901,378 860,087

Operating lease right-of-use asset 2,897,007 2,955,873

Deferred income taxes, net 1,692,445 1,663,415

Other assets 266,757 232,002

Total assets 68,367,961 66,728,864

Current liabilities:

Accounts payable 873,332 993,742

Accrued payroll and benefits 1,623,375 2,166,209

Other accrued taxes 126,826 596,576

Warranty reserve 89,685 81,761

Deferred revenue 1,814,209 1,671,420

Current portion of operating lease liability 244,474 240,843

Other current liability 108,421 108,421

Total current liabilities 4,880,322 5,858,972

Deferred revenue 2,773,802 2,630,467

Operating lease liability, less current portion 2,652,533 2,715,030

Total liabilities 10,306,657 11,204,469

Stockholders' equity:

Common stock; $0.0001 par value; 31,500,000 shares authorized; 11,970,937 shares issued and outstanding as of March 31, 2020 and 11,765,875 shares issued and outstanding as of December 31, 2019 1,197 1,177

Additional paid-in capital 19,949,639 19,192,394

Retained earnings 38,069,661 36,300,450

Accumulated other comprehensive income 40,807 30,374

Total stockholders' equity 58,061,304 55,524,395

Total liabilities and stockholders' equity $ 68,367,961 $ 66,728,864

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765
+ Details

Name: us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045
+ Details

Name: us-gaap_ContractWithCustomerLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044
+ Details

Name: us-gaap_ContractWithCustomerLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of investment in debt security measured at amortized cost (held-to-maturity), investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at fair value with change in fair value recognized in net income (trading); classified as current.
+ References
No definition available.
+ Details

Name: us-gaap_DebtSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredIncomeTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6904-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6911-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)(4)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6787-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5865-108316

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12524-110249

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 25
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68070138&loc=d3e11281-110244
+ Details

Name: us-gaap_ProductWarrantyAccrualClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 64 R6.htm IDEA: XBRL DOCUMENT v3.20.1

CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)
3 Months Ended

Mar. 31, 2020

Mar. 31, 2019

STATEMENTS OF COMPREHENSIVE INCOME

Change in fair value of available-for-sale securities, net of tax expense $ 3,442 $ 11,656

Realized loss on available-for-sale securities reclassified to net income, net of tax expense (benefit) $ 0 $ 949

X

- Definition
Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683
+ Details

Name: us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=114867106&loc=d3e640-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27357-111563
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 65 R47.htm IDEA: XBRL DOCUMENT v3.20.1

Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details)
3 Months Ended

Mar. 31, 2020

USD ($)

shares

Stock Options

Stock Options

Outstanding beginning of period (in shares) 638,860

Awards exercised/vested (in shares) (190,540)

Awards cancelled (in shares) (500)

Outstanding end of period (in shares) 447,820

Restricted Stock Units

Total unrecognized compensation expense | $ $ 500,552

Weighted-average period expected to be recognized 3 years 4 months 24 days

Restricted Stock Units

Restricted Stock Units

Outstanding beginning of period (in shares) 297,048

Awards granted (in shares) 18,129

Awards exercised/vested (in shares) (19,844)

Awards cancelled (in shares) (25,724)

Outstanding end of period (in shares) 269,609

Total unrecognized compensation expense | $ $ 4,805,263

Weighted-average period expected to be recognized 3 years 1 month 6 days

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Unrecognized cost of unvested options awarded to employees as compensation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 66 R43.htm IDEA: XBRL DOCUMENT v3.20.1

Investments (Details) - USD ($)
3 Months Ended 12 Months Ended

Mar. 31, 2020

Dec. 31, 2019

Investments

Cost $ 2,729,825 $ 2,729,825

Gross Unrealized Gains 52,337 38,462

Fair Value 2,782,162 2,768,287

U.S. corporations

Investments

Cost 2,258,686 2,258,686

Gross Unrealized Gains 45,342 29,123

Fair Value 2,304,028 2,287,809

International corporations

Investments

Cost 471,139 471,139

Gross Unrealized Gains 6,995 9,339

Fair Value $ 478,134 $ 480,478

X

- Definition
Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109979856&loc=d3e26610-111562

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of unrealized gain on investment in debt security measured at fair value with change in fair value recognized in net income (trading).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=82897076&loc=d3e27357-111563
+ Details

Name: us-gaap_DebtSecuritiesTradingUnrealizedGain

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_InvestmentHoldingsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amortized cost of investments in debt securities classified as trading.
+ References
No definition available.
+ Details

Name: us-gaap_TradingSecuritiesDebtAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 67 R22.htm IDEA: XBRL DOCUMENT v3.20.1

Basis of Presentation (Policies)
3 Months Ended

Mar. 31, 2020

Basis of Presentation

Certain Significant Risks and Uncertainties

Certain Significant Risks and Uncertainties

We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses.

COVID-19 Considerations

We are subject to risks and uncertainties as a result of the spread of COVID-19. The extent of the impact of COVID-19 on our business is highly uncertain and difficult to predict. Our future results of operations and liquidity could be adversely impacted by delays in payments, supply chain disruptions, and uncertain demand. As of the date of the issuance of these financial statements, the extent to which COVID-19 may materially impact our financial condition, liquidity, or results of operations in future periods is uncertain.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Recently Issued Accounting Pronouncements to be Implemented

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 will be effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We do not expect ASU 2019-12 to have a material impact on financial condition, results of operations or cash flows.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. In November 2018, April 2019 and May 2019, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses and ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, which provided additional implementation guidance on ASU 2016-03. The previously mentioned ASUs are effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We do not expect the adoption of these ASUs to have a material impact on our financial condition, results of operations or cash flows.

X

- Definition
Disclosure of accounting policy for credit risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 825
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788
+ Details

Name: us-gaap_ConcentrationRiskCreditRisk

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 68 R26.htm IDEA: XBRL DOCUMENT v3.20.1

Property and Equipment (Tables)
3 Months Ended

Mar. 31, 2020

Property and Equipment

Schedule of property and equipment



March 31,



December 31,

2020

2019

(unaudited)

Computer software and hardware

$

647,988

$

627,624

Furniture and fixtures

1,117,693

1,112,550

Leasehold improvements

225,841

225,841

Machinery and equipment

1,796,394

1,778,524

Tooling in-process

291,642

163,105

4,079,558

3,907,644

Accumulated depreciation

(1,979,780)

(1,853,838)

Total

$

2,099,778

$

2,053,806

Schedule of property and equipment, net, information by geographic region



March 31,



December 31,

2020

2019

(unaudited)

United States

$

1,757,458

$

1,689,740

International

342,320

364,066

Total property and equipment, net

$

2,099,778

$

2,053,806

X

- Definition
Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph b
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599
+ Details

Name: us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
CONDENSED BALANCE SHEETS
Accounts receivable, allowance for doubtful accounts	$ 104,547	$ 69,093
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	31,500,000	31,500,000
Common stock, shares issued	11,970,937	11,765,875
Common stock, shares outstanding	11,970,937	11,765,875

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income	Total
Balances at Dec. 31, 2018	$ 1,099	$ 15,317,335	$ 26,669,491	$ (42,192)
Increase (Decrease) in Stockholders' Equity
Net income			1,845,565		$ 1,845,565
Other comprehensive income				38,194
Stock-based compensation		382,353
Net share settlement of restricted stock units		(22,507)
Exercise of stock options and warrants	15	456,724
Balances at Mar. 31, 2019	1,114	16,133,905	28,515,056	(3,998)	44,646,077
Balances at Dec. 31, 2019	1,177	19,192,394	36,300,450	30,374	55,524,395
Increase (Decrease) in Stockholders' Equity
Net income			1,769,211		1,769,211
Other comprehensive income				10,433
Stock-based compensation		568,958
Net share settlement of restricted stock units	1	(133,873)
Exercise of stock options and warrants	19	322,160
Balances at Mar. 31, 2020	$ 1,197	$ 19,949,639	$ 38,069,661	$ 40,807	$ 58,061,304

Stock-Based Compensation (Details) - USD ($)	3 Months Ended
Stock-Based Compensation (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Stock-Based Compensation
Total stock-based compensation expense	$ 568,958	$ 382,353
Cost of revenue
Stock-Based Compensation
Total stock-based compensation expense	58,254	62,524
General and administrative
Stock-Based Compensation
Total stock-based compensation expense	362,152	219,705
Sales and marketing
Stock-Based Compensation
Total stock-based compensation expense	130,955	82,131
Research and development
Stock-Based Compensation
Total stock-based compensation expense	$ 17,597	$ 17,993

Intangible Assets (Details) - USD ($)	3 Months Ended
Intangible Assets (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Intangible assets
Intangible Assets, gross	$ 1,463,056		$ 1,399,274
Accumulated amortization	(561,678)		(539,187)
Total	901,378		860,087
Amortization expense of intangible assets	22,491	$ 22,491
Expected annual amortization expense
Nine months ending December 31, 2020	67,472
2021	89,963
2022	89,392
2023	88,740
2024	88,439
2025	87,446
Patents - in use
Intangible assets
Intangible Assets, gross	304,270		304,270
Patents - in process
Intangible assets
Intangible Assets, gross	139,641		120,581
Internally developed software - in use
Intangible assets
Intangible Assets, gross	867,569		867,569
Internally developed software - in process
Intangible assets
Intangible Assets, gross	124,808		80,721
Trademarks
Intangible assets
Intangible Assets, gross	$ 26,768		$ 26,133

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2020
Income Taxes
Income Taxes	11 — Income Taxes For the three months ended March 31, 2020, we recorded a provision for income tax benefit of $(933,474). Our effective tax rate was (111.7) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation and a U.S. state tax benefit. Additionally, we recognized a benefit in our effective tax rate resulting from the Coronavirus Aid, Relief, and Economic Security Act, which allowed us to carryback the net operating loss to years prior to the enactment of the Tax Cuts and Jobs Act. For the three months ended March 31, 2019, we recorded a provision for income tax benefit of $(239,146). Our effective tax rate was (14.9) percent and differed from the U.S. Federal statutory rate primarily due to discrete items related to tax benefits associated with stock-based compensation, partially offset by U.S. state tax expense. As of March 31, 2020 and December 31, 2019, we had not identified or accrued for any uncertain tax positions. We are currently unaware of any uncertain tax positions that could result in significant payments, accruals or other material deviations in this estimate over the next 12 months. We believe that our tax positions comply in all material respects with applicable tax law. However, tax law is subject to interpretation, and interpretations by taxing authorities could be different from ours, which could result in the imposition of additional taxes and penalties. We file tax returns in the United States Federal jurisdiction and many U.S. state jurisdictions. The Company is subject to income tax examinations for our United States Federal and certain U.S. state income taxes for 2016 and subsequent years and various other U.S. state income taxes for 2015 and subsequent years.

Revenue Recognition - Capitalized Contract Costs (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Revenue Recognition
Capitalized contract costs	$ 412,863	$ 352,250
Expense related to amortization of capitalized contract costs	$ 28,169	$ 22,713

Basis of Presentation (Details)	3 Months Ended
Basis of Presentation (Details)	Mar. 31, 2020 segment
Basis of Presentation
Number of reportable segment	1

Commitments and Contingencies (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Purchase commitments
Purchase commitments	$ 3,631,996	$ 3,208,174

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 44,636,348	$ 43,481,781
Accounts receivable, net of allowance for doubtful accounts of $104,547 as of March 31, 2020 and $69,093 as of December 31, 2019	5,851,843	7,293,303
Investments	2,782,162	2,768,287
Inventory, net	4,214,961	3,641,561
Prepaid expenses and other current assets	753,334	407,802
Prepaid income taxes	2,271,948	1,370,947
Total current assets	60,510,596	58,963,681
Property and equipment, net	2,099,778	2,053,806
Intangible assets, net	901,378	860,087
Operating lease right-of-use asset	2,897,007	2,955,873
Deferred income taxes, net	1,692,445	1,663,415
Other assets	266,757	232,002
Total assets	68,367,961	66,728,864
Current liabilities:
Accounts payable	873,332	993,742
Accrued payroll and benefits	1,623,375	2,166,209
Other accrued taxes	126,826	596,576
Warranty reserve	89,685	81,761
Deferred revenue	1,814,209	1,671,420
Current portion of operating lease liability	244,474	240,843
Other current liability	108,421	108,421
Total current liabilities	4,880,322	5,858,972
Deferred revenue	2,773,802	2,630,467
Operating lease liability, less current portion	2,652,533	2,715,030
Total liabilities	10,306,657	11,204,469
Stockholders' equity:
Common stock; $0.0001 par value; 31,500,000 shares authorized; 11,970,937 shares issued and outstanding as of March 31, 2020 and 11,765,875 shares issued and outstanding as of December 31, 2019	1,197	1,177
Additional paid-in capital	19,949,639	19,192,394
Retained earnings	38,069,661	36,300,450
Accumulated other comprehensive income	40,807	30,374
Total stockholders' equity	58,061,304	55,524,395
Total liabilities and stockholders' equity	$ 68,367,961	$ 66,728,864

Stock-Based Compensation - Stock Options and Restricted Stock Units Activity (Details)	3 Months Ended
	Mar. 31, 2020 USD ($) shares
Stock Options
Stock Options
Outstanding beginning of period (in shares)	638,860
Awards exercised/vested (in shares)	(190,540)
Awards cancelled (in shares)	(500)
Outstanding end of period (in shares)	447,820
Restricted Stock Units
Total unrecognized compensation expense \| $	$ 500,552
Weighted-average period expected to be recognized	3 years 4 months 24 days
Restricted Stock Units
Restricted Stock Units
Outstanding beginning of period (in shares)	297,048
Awards granted (in shares)	18,129
Awards exercised/vested (in shares)	(19,844)
Awards cancelled (in shares)	(25,724)
Outstanding end of period (in shares)	269,609
Total unrecognized compensation expense \| $	$ 4,805,263
Weighted-average period expected to be recognized	3 years 1 month 6 days

Investments (Details) - USD ($)	3 Months Ended	12 Months Ended
Investments (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Investments
Cost	$ 2,729,825	$ 2,729,825
Gross Unrealized Gains	52,337	38,462
Fair Value	2,782,162	2,768,287
U.S. corporations
Investments
Cost	2,258,686	2,258,686
Gross Unrealized Gains	45,342	29,123
Fair Value	2,304,028	2,287,809
International corporations
Investments
Cost	471,139	471,139
Gross Unrealized Gains	6,995	9,339
Fair Value	$ 478,134	$ 480,478

Basis of Presentation (Policies)	3 Months Ended
Basis of Presentation (Policies)	Mar. 31, 2020
Basis of Presentation
Certain Significant Risks and Uncertainties	Certain Significant Risks and Uncertainties We market our products to end users in the United States and to distributors internationally. Sales to end users in the United States are generally made on open credit terms. Management maintains an allowance for potential credit losses. COVID-19 Considerations We are subject to risks and uncertainties as a result of the spread of COVID-19. The extent of the impact of COVID-19 on our business is highly uncertain and difficult to predict. Our future results of operations and liquidity could be adversely impacted by delays in payments, supply chain disruptions, and uncertain demand. As of the date of the issuance of these financial statements, the extent to which COVID-19 may materially impact our financial condition, liquidity, or results of operations in future periods is uncertain.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Recently Issued Accounting Pronouncements to be Implemented In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 will be effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. We do not expect ASU 2019-12 to have a material impact on financial condition, results of operations or cash flows. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the Company to measure and recognize expected credit losses for financial assets held and not accounted for at fair value through net income. In November 2018, April 2019 and May 2019, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses and ASU 2019-05, Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief, which provided additional implementation guidance on ASU 2016-03. The previously mentioned ASUs are effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We do not expect the adoption of these ASUs to have a material impact on our financial condition, results of operations or cash flows.